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SUMMARY   
 
HIV-positive employees that receive treatment for HIV/AIDS by having their employers 
pay for the treatment are being taxed on their lifesaving HIV benefits paid by their 
employer. 
 
This comes after the Commissioner of Inland Revenue (CIR) or South African Revenue 
Service (SARS) identified the provision of treatment by employers as a “fringe benefit” 
in terms of paragraphs 2(e), 2(h) and 2(i) of the Seventh Schedule to the Income Tax Act1  
and as such is taxable if the treatment is given from the work place. 
 
The treatment contribution is included in an employee’s remuneration package as a fringe 
benefit. Pay-as-you-earn (PAYE) and other assessed taxes are calculated from that. The 
taxable benefit is included on the employees’ annual IRP5 certificates. In order for the 
employer’s Human Resources department to affect this on the IRP 5 certificates the 
affected employee has to disclose his HIV/AIDS status and accordingly pay the PAYE on 
the fringe benefit. 
 
In terms of paragraph 2(e) of the Seventh Schedule to the Income Tax Act No. 58 of 
1962, any service rendered at the expense of the employer to the employee, whether by 
the employer or by some other person, which has been utilised by the employee for 
private or domestic use, such value of the service must be included in the employee’s 
consideration for remuneration. 
 
Paragraph 2(h)2 taxes the employees on debts paid by the employer on behalf of the 
employees and paragraph 2(i)3 taxes a one third contribution benefit back in the hand of 
an employee for contributions to medical aids. If the employee were to receive chronic 
medication from a medical aid for HIV/AIDS treatment this will be included in the fringe 
benefit tax as a medical contribution. 
                                                 
1 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
2 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
3 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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The Employment Equity Act No. 55 of 19984 promotes the elimination of unfair 
discrimination in the work place and ensures the implementation of Employment Equity 
to redress the effects of discrimination. Above all it also promotes the constitutional right 
to equality.  In terms of confidentiality of the employees HIV/AIDS status; the Income 
Tax Act No. 58 of 1962 (Income Tax Act)5  as interpreted seems to be in conflict with the 
Employment Equity Act No. 55 of 1998. 
 
A solution therefore has to be sought where: 
 The anonymity of an employee in terms of his/her HIV/AIDS status is protected as 
envisaged by the Employment Equity Act6.  
 It is also necessary to understand whether there is in fact conflict between the Income 
Tax Act7 and the Employment Equity Act8.   
 It is also necessary to establish whether there are any misconceptions in the 
interpretation of the legislation and  
 Try to find the best possible solution to minimise the impact of Income Tax and yet 
protect the confidentiality of the employees concerned.  
 
 
 
 
 
 
 
 
 
 
 
                                                 
4  Employment Equity Act 55 of 1998 
5  Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
6 Employment Equity Act 55 of 1998 
7 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
8 Employment Equity Act 55 of 1998 
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OPSOMMING 
 
MIV-positiewe werknemers wat behandeling vir MIV/VIGS ontvang by hul werkgewers 
word belas op hul lewensreddende MIV voordele wat deur hul werkgewers betaal word.  
 
Hierdie word bepaal nadat die Kommisaris van Binnelandse Inkomste (KBI) of die Suid-
Afrikaanse Belastingsdiens (SAB) die voorsiening van behandeling deur werkgewers ag 
as ‘n belastingbyvoordeel in terme van paragrawe 2(e), 2(h) en 2(i) van die Sewende 
Skedule van die Inkomste belastingwet9 indien die diens gelewer word buite die 
werksplek.  
 
Die bydrae tot behandeling word ingesluit in die werknemer se vergoedingspakket as ‘n 
belasbare byvoordeel. Werknemersbelasting of LBS en ander aangeslaande belastings 
word hiervandaan bereken. Die byvoordeel word op die werknemer se IRP5 sertifikaat 
aangedui. Om hierdie aan te dui op die IRP5 sertifikaat van die geaffekteerde werknemer 
moet die werknemer se MIV status aan die werkgewer se Menslike Hulpbron 
departement bekend wees om die nodige byvoordeel te bereken. 
 
In terme van paragraaf 2(e)10 van die Sewende Skedule van die Inkomste Belastingwet 
nr. 58 van 1962, word enige diens gelewer deur die werkgewer namens die werknemer, 
of deur die werkgewer of deur sekere ander persone, wat gebruik word deur die 
werknemer vir privaat en huishoudelike gebruik geag as vergoeding te wees en die diens 
moet ingesluit wees in die vergoedingspakket. 
 
Paragraaf 2(h)11 belas die werknemers op skuld betaal namens die werknemer deur die 
werkgewer en paragraaf 2(i)12 belas een derde van die bydrae terug in die hand van die 
werknemer vir bydraes betaal deur die werkgewer aan mediese fondse. Indien die 
                                                 
9 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
10 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
11 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
12 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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werknemer kroniese medikasie ontvang van die mediese fonds vir MIV/VIGS 
behandeling sal dié belas word as ‘n belasbare byvoordeel.  
 
Die Gelyke Indiensnemingwet nr 55 van 199813 bevorder die eliminasie van 
ongeregmatige diskriminasie in die werksplek en verseker dat die implementasie van die 
wetgewing die impak van diskrimasie reg aanspreek. Die wetgewing bevorder die 
konstitisionele reg tot gelykheid. In terme van die vertroulikheid van die MIV/VIGS 
status van werknemers bleik die Inkomstebelastingwet  in konflik te wees met die Gelyke 
Indiensnemingswetgewing. 
 
‘n Oplossing moet dus gevind word, waar: 
 
 Die anonimiteit van die werknemers in terme van hul MIV/VIGS status beskerm 
word soos veronderstel word in die Indiensnemingsekwiteitswetgewing 
 Dit is ook nodig om te verstaan of daar inderdaad konflik is tussen die onderskeie 
wetgewings, naamlik die Inkomstebelastingwet en die 
Indiensnemingsekwiteitswetgewing. 
 Dit is ook belangrik om te bepaal of daar enige miskonspesies in die interpretasie van 
die wetgewing is en  
 Om te probeer om die bes moontlike oplossing te vind om die impak van 
Inkomstebelasting te verminder en terselfdertyd die konfidensialiteit van die 
werknemers te verseker. 
 
 
 
 
 
 
 
 
                                                 
13 Employment Equity Act 55 of 1998 
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1.  BACKGROUND MEDICAL FACTS CONCERNING HIV/AIDS18 
 
HIV is known as the Human Immunodeficiency (Retro) Virus, with a unique enzyme that 
enables the virus to multiply in living human cells.  
 
The human body fights the attack of the virus through the immune system but the process 
of multiplication tires out the immune system and leads to AIDS (Acquired Immune 
Deficiency Syndrome). 
 
Through mathematical modelling the origin of the virus was traced and indicates that the 
mutation of the HIV 1 virus occurred as late back as the 1930’s and had probably entered 
the human race from chimpanzees, probably through contamination of human blood with 
infected chimpanzees through the slaughtering process. A similar virus exists in the 
chimpanzee population, the Simian Immunodeficiency Virus (SIV).  
 
The African epidemic began in the 1970’s as a heterosexual epidemic in East Africa from 
where it spread to other areas.  
 
As many as 15 different types of viruses exist and the subtype B virus in South Africa 
originated in the 1980’s from the homosexual HIV/AIDS epidemic overseas. 
 
The subtype C virus in South Africa arrived mainly from heterosexual migrant labourers 
and truck drivers towards the end of the 1980’s.  
 
                                                 
18 E Bokelman, assignment 1, MPhil, epidemiology from Prof E Van Rensburg, Notes on epidemiology, 
module 1, 2004, MPhil in HIV/AIDS, University of Stellenbosch,  
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Source: WHO Epidemiological Fact Sheets on HIV/AIDS and Sexually Transmitted Diseases, 2002 
update19 
 
 
The HIV is transmitted via body fluids from people who are infected with the virus. 
Examples of body fluids are; semen, secretions of the prostate gland and vagina, breast 
milk and infected blood. Infected body fluids such as tears, saliva and urine contain very 
low concentrations of the virus and are not considered a risk for infection. 
 
High risk factors considered to lead to HIV infection are: 
 Multiple sex partners 
 Unprotected sex (not using condoms) 
 Intravenous drug use or needle stick injuries (sharing of contaminated needles) 
 An infected mother and her child during childbirth and breastfeeding. 
 
                                                 
19 WHO, 2002 update, Epidemiological fact Sheets on HIV/AIDS and Sexually Transmitted Diseases,  
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The HIV enters cells predominantly via host cells known as CD4+ T receptor cells. These 
cells are always present when cells are infected. The infection is detected through a 
process of inflammation of the infected sites. The body’s immune system recognises the 
virus or components of the virus as being invaders when infected with the virus. The 
immune system’s response to these foreign substances is an attack on these substances by 
trying to eliminate them from the body through the formation of antibodies by the white 
blood cells. 
 
An HIV test detects the antibodies to HIV in the blood and confirms that a person was in 
fact infected. Through Rapid HIV assays a drop of blood from a finger prick can be used 
to determine one’s HIV status and the test results are available immediately.  
 
If the HIV Rapid test gives a positive result, a confirmatory laboratory test needs to be 
conducted through a process of venepuncture (taking blood through a needle stick) or 
another Rapid assay from another medical supplier of Rapid HIV screening tests.  
 
HIV infection has a major impact on one’s social and family life and carries with it a 
corresponding death sentence if the infection goes undetected and untreated, the virus 
being undetected leads to AIDS (where the AIDS patient will probably die in 7-10 years). 
  
The emotional effect of the infection on the individual is that it causes internal conflict as 
the individual is in a precarious situation where it is necessary to tell people; family and 
friends of the HIV+ status but yet the social impact of discrimination and stigmatisation 
is too much to handle. It places a further responsibility on the individual to consider other 
people, whilst being traumatised by a possible death sentence that can be placed on 
sexual partners through sexual intercourse or children through childbirth, if the HIV 
positive status is not disclosed.   
 
ARV’s (Anti-Retroviral) refer to the drugs used in the treatment of HIV/AIDS. ARV’s 
inhibit the replication of the viruses. The drugs not only intercept but also target specific 
steps in the life cycle of the virus. 
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Amongst epidemiologists, pathologists and HIV/AIDS experts it is generally accepted 
that it is impossible to eradicate the HIV disease with the current ARV combination 
therapies in use. The immediate effect of successful ARV treatment is a suppression of 
the viral load, this allows the immune system to recover and regain its function through a 
process known as immune reconstitution. This results in a rise of CD4 cells and an 
improvement in their function. The recovered immune system can ward off intruders and 
reduce the risk of HIV-associated diseases. Less infections result in better quality of life 
and ultimately longer survival. 
 
With HAART (Highly Active Anti- Retroviral treatment), HIV becomes manageable 
rather than a deadly disease. ARV therapy has toxic side effects as well as other side 
effects but despite this the advantages of the therapy lead to survival. 
 
The challenges and difficulties that an individual on ARV therapy experience are the 
following: 
 The high cost and availability of medicine  
 The difficulty to take drugs due to the discipline involved in taking the drugs 
regularly  
 Different drugs and combinations have different side effects. 
 Different drugs have different toxicity profiles and therefore different systems and 
organs of the body can be affected depending on the drugs prescribed. 
 Strict adherence to combination ARV therapy is necessary otherwise resistance 
will soon develop.  
 Disturbing changes take place in body composition of the person on ARV 
treatment.   
 To add to the distress is the fact that if the individual’s employer pays for his 
treatment “off-site”, the South African Revenue Services (SARS) taxes the 
benefit as a fringe benefit and makes the cost of treatment even higher. 
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2.  STATISTICS AND DEMOGRAPHICS OF THE HIV/AIDS EPIDEMIC 
 
Statistics show that more than 20 million people have already died of AIDS20. Between 
34 and 46 million people live with HIV/AIDS21 of which 25 to 28 million people are 
from Sub-Saharan Africa.22  As many as 5 million people were newly infected with HIV 
(over 3 million in sub-Saharan Africa) and 2,3 million died as a result of AIDS in 2003.23  
 
A summary of the HIV/AIDS epidemic as supplied by UNAIDS a division of the World 
Health Organisation (WHO):24 
 Population Estimate Range 
Number of people living with 
HIV/AIDS Total 40 million (34 – 46 million) 
 Adults 37 million (31 – 43 million) 
 
Children under 15 
years 2.5 million (2.1 – 2.9 million) 
People newly infected with HIV in 
2003 Total 5 million (4.2 – 5.8 million) 
 Adults 4.2 million (3.6 – 4.8 million) 
 
Children under 15 
years 700 000 (590 000 – 810 000) 
AIDS deaths in 2003 Total 3 million (2.5 – 3.5 million) 
 Adults 2.5 million (2.1 – 2.9 million) 
 
Children under 15 
years 500 000 (420 000 – 580 000) 
    
Source: Global summary of the HIV/AIDS epidemic, December 2003 UNAIDS 
 
The HIV/AIDS prevalence rate in South Africa is currently estimated at 17,1% based on 
tests performed on 101 202 pregnant women at Government clinics,25 by the Department 
of Health,  but exact figures are not available. By the end of 2002 as many as 5 million 
                                                 
20 Joint United Nations Programme on HIV/AIDS (UNAIDS), HIV/AIDS, human resources and sustainable 
development, paper presented at the World Summit on Sustainable Development Johannesburg 2002. 
21Joint United Nations Programme on HIV/AIDS (UNAIDS), Global AIDS epidemic shows no sign of 
abating: highest number of HIV infections and deaths ever Press Release accessed at www.unaids.org  
22Joint United Nations Programme on HIV/AIDS (UNAIDS), Global AIDS epidemic shows no sign of 
abating: highest number of HIV infections and deaths ever Press Release accessed at www.unaids.org . 
23 Joint United Nations Programme on HIV/AIDS (UNAIDS), Global AIDS epidemic shows no sign of 
abating: highest number of HIV infections and deaths ever Press Release accessed at www.unaids.org  
24 UNAIDS, December 2003, Global summary of the HIV/AIDS epidemic,  
25 South African Government, 19 March 2003, Update on the national HIV and AIDS programme.  
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people in South Africa were HIV-positive and seem to be the highest number in any 
country in the world.26  
 
WORLD DEMOGRAPHICS OF HIV/AIDS PREVALENCE27 
 
Source: Global summary of the HIV/AIDS epidemic, December 2003 UNAIDS 
 
The Department of Health in South Africa conducts a national HIV and syphilis sero-
prevalence survey annually in October each year, through sampling from 396 clinics 
throughout South Africa. The statistics 28 are drawn from information gathered from 
predominantly Black females, who predominantly frequent these clinics. These women 
visiting these clinics are normally pregnant and therefore women in their fertile years. 
The information can therefore not be extrapolated to the population at large, but it gives 
us a good indication how HIV prevalence has progressed. The following data and graph 
extracted from this survey demonstrates the increase in HIV prevalence:  
                                                 
26 Joint United Nations Programme on HIV/AIDS (UNAIDS), Global AIDS epidemic shows no sign of 
abating: highest number of HIV infections and deaths ever Press Release accessed at www.unaids.org  
27 UNAIDS 2002, Report on the global HIV/AIDS epidemic, Geneva, Switzerland, September 2003,  
28 National HIV and Syphilis Antenatal Sero-prevalence Survey in South Africa: 2002 report 
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Source: National HIV and Syphilis Antenatal Sero-prevalence Survey in South Africa: 2002 report29 
 
Figures released in February 200530 by Statistics South Africa from a National mortality 
study states that deaths had risen from 318 287 in 1997 to 499 268 in 2002. The death 
rate amongst adults over 15 had increased by 62%. The report further shows that the 
death rate had increased the most amongst women aged between 20 and 49. Females in 
the category 20 to 49 are also regarded as the most vulnerable to HIV/AIDS. The study 
seems to give indirect evidence of the fact that HIV/AIDS raises the mortality rates of 
prime aged adults.  
 
 
                                                 
29 National HIV and Syphilis Antenatal Sero-prevalence Survey in South Africa: 2002 report 
30 The Weekend Argus, February 19 2005 
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3.  FINANCIAL IMPACT OF HIV/AIDS IN THE WORLD OF WORK  AND THE 
MOTIVATION FOR HIV/AIDS WORLD OF WORK PROGRAMMES 
  
“Death from AIDS of working age adults is a real an immediate crisis”; according to the 
opposition Democratic Alliance, in response to the Statistics South Africa mortality 
report as reported in the Weekend Argus of 19 February 2005. He furthermore states: 
“Many of the adults who are dying include nurses and teachers, are critical to South 
Africa’s future. Yet the Government has no comprehensive human resources plan in 
place to address this”.  
 
The disease therefore has a macro-economic impact as well as a micro-economic impact 
in the World of Work.  
 
The financial impact of the HIV/AIDS epidemic in the World of Work is manifested 
through loss of productivity. There is increased disorganisation in the work place as a 
result of the loss of productivity caused by morbidity and mortality. The morbidity leads 
to absenteeism as a result of ill health, or colleagues attending funerals of deceased 
colleagues or family members. Morbidity further leads to increased staff turnover due to 
accommodation of infected and affected employees in the work place (with different job 
descriptions or posts) and eventual loss of skills due to mortality. The resultant drain of 
skills of highly trained or educated employees are lost to the work force and there is the 
continuous pressure by employers to train new employees. All of this disorganisation and 
loss of productivity weaken the staff morale and the financial resources of the employer 
companies. 
 
The financial cost of the pandemic and the financial impact on a company is difficult to 
quantify accurately. The cost to specific companies varies because of various factors such 
as geographic location, industry sector and the degree of dependence on labour.  
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Actuarial studies at AngloGold Limited for instance forecast that by 2009 HIV/AIDS-
related costs will be between 8% and 17% of the company’s payroll31. At the end of 
December 2002 the payroll amounted to $392 million. AngloGold, as South Africa’s 
second-largest employer with as many as 44 828 employees,32 provided ARV treatment 
for infected workers at a cost of R2 440 per month per worker. The budget for new 
HIV/AIDS intervention programmes in 2003 was R7,4 million. 
 
Forecasts from the Department of Labour in a published article in June 2003 predict that 
3% of the South African workforce (about 500 000 people) will have full-blown AIDS by 
2010.33 The South African work force adds up to about 16,67 million people and the cost 
to companies of HIV/AIDS work place programmes vary between R220 and R480 a year 
per employee. The total cost of these work place programmes will therefore add up to   
R5 833 million per year (R350 x 16,67 million), this excludes the financial impact of loss 
of productivity due to mortality or morbidity or the financial loss for an affected family . 
 
The vulnerability of companies can be measured by making financial impact projections 
based on published HIV/AIDS prevalence rates for different regions or the country as a 
whole.  
HIV/AIDS prevalence statistics as per the ASSA model34 show the typical impact on the 
World of Work in terms of HIV/AIDS; it gives an idea of the probable percentage of the 
workforce that will need ARV treatment. (This enables one to ascertain the materiality of 
the fringe benefit tax on the company’s payroll.) 
                                                 
31 Financial Mail, Corporate AIDS awareness,  6 December 2002. 
32 Financial Mail, Corporate AIDS awareness,  6 December 2002. 
33 Mail & Guardian, 4 June 2003, Shock Figures on HIV/AIDS in Workplace. 
34 Dorrington, R E, Bradshaw D & Budlender D, HIV/AIDS profile in the provinces of South Africa, Indicators for 
South Africa (ASSA model 2000), Centre for Actuarial Research, Medical Research Council, Actuarial Society of 
South Africa, 2002  
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A prevalence rate is the percentage of a group that is infected by HIV at a particular time 
and the rates in the ASSA model 35 are classified in the different provinces of South 
Africa in different categories and distinguish between gender and age bands. 
Other statistics36 in South Africa make further distinctions in terms of style (race) and 
specific age bands. 
Through the statistics supplied by the ASSA model 37 a company can make an assessment 
of the potential financial impact in the World of Work or work place specifically and re-
assess the situation as the future demographics of the company change. A mathematical 
projection is made with the estimated prevalence for gender and race and designation 
given the cost-to-company of the employees. 
 
It is with this potential prevalence rate that the company normally embarks on a 
Voluntary Counselling and Training (VCT) programme where the employees then get to 
know their HIV status. Knowing their status is all fair and well but owning their status 
involves social, cultural, psychological and medical issues that the employee is not 
equipped to finance with his monthly income. The employee needs HIV/AIDS Disease 
Management or medical treatment if diagnosed as HIV positive. The company in turn 
wants a healthy work force, as a healthy work force equates to production and if the 
company is financially secure and healthy it would be sustainable and the income of the 
employees will therefore be sustainable.  The employer augments the income of the 
employee to make the treatment of the disease affordable by paying for the HIV/AIDS 
Disease Management. As such the employer is securing the health of the company’s 
human capital and therefore as the expense is incurred in the production of income it is a 
section 11(a) deduction for Income Tax purposes.38 
                                                 
35 Dorrington, R E, Bradshaw D & Budlender D, HIV/AIDS profile in the provinces of South Africa, Indicators for 
South Africa (ASSA model 2000), Centre for Actuarial Research, Medical Research Council, Actuarial Society of 
South Africa, 2002  
36 Progress report on the Global response to the HIV/AIDS Epidemic 2003, UNAIDS, Geneva, Switzerland, September 
2003 
37 Dorrington, R E, Bradshaw D & Budlender D, HIV/AIDS profile in the provinces of South Africa, Indicators for 
South Africa (ASSA model 2000), Centre for Actuarial Research, Medical Research Council, Actuarial Society of 
South Africa, 2002 
38 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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The tax deductibility of Awareness, Training and VCT should not be questioned as this is 
seen as a normal section 11(a) deduction. 
 
“11.   General deductions allowed in determination of taxable income.—For the purpose 
of determining the taxable income derived by any person from carrying on any trade, 
there shall be allowed as deductions from the income of such person so derived— 
(a) expenditure and losses actually incurred in the production of 
the income, provided such expenditure and losses are not of a 
capital nature…”39. 
 
Many initiatives exist that put pressure on the World of Work to proactively protect their 
human capital by making use of HIV/AIDS Awareness and Training programmes either 
internally or through external consultants.   
 
Voluntary Counselling and Testing (VCT) programmes are conducted in the World of 
Work as prescribed in the Employment Equity Act40. The VCT process makes the 
individual employee aware of his or her HIV/AIDS status and as such the employee or 
employer can take the necessary action for the employee to maintain the HIV negative 
status or if HIV positive to get involved in HIV/AIDS Disease Management programmes. 
 
Course material presented by the Department of Virology on Epidemiology University of 
Stellenbosch, Prof Estrilita Van Rensburg41; discuss different stages, five in total of AIDS 
progression caused by HIV and if undetected an individual will die within 10 years of 
contracting the disease. Once the employee knows his HIV status and has been taken care 
of by a medical practitioner or Disease Management programme, the employee’s life can 
                                                 
39 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
40 Employment Equity Act 55 of 1998 
41 Prof E Van Rensburg, Notes on epidemiology, module 1, 2004, MPhil in HIV/AIDS, University of 
Stellenbosch 
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be prolonged considerably. It is known that with the correct care and treatment an 
individual can lead a normal life.   
The VCT- and Disease Management treatment consist of: 
 Determining the HIV status of the employee through a Rapid test procedure either 
by testing the saliva of the individual or doing a finger prick test after the 
employee has been given pre-test counselling. 
 Confirmation of the HIV status of the employee by way of an ELISA laboratory 
testing procedure where blood is drawn from the individual and the blood samples 
are sent to a laboratory for screening and testing. 
 The employee’s status is divulged at a post-test counselling session at which time 
a confirmatory ELISA test is normally conducted. 
 Once the HIV status has been confirmed as positive CD4 laboratory testing on 
blood samples will determine how far the disease has progressed (Stage 1 -5).  
 The CD4 count is an indication of the resistance of the immunological system of 
the individual to the disease. A low CD4 count indicates that treatment should 
start.   
 In South Africa treatment generally starts at a CD4 count of 200. 
 ARV treatment is administered by choosing the correct ARV combination or 
regime.  
 The ARV treatment often has adverse side effects and therefore the individual 
needs to be monitored. 
The effect of the treatment furthermore has to be monitored by taking further blood 
samples to be screened at a pathology laboratory to determine whether the individual’s 
CD4 count improves. 
 
If the employer were to pay for the Disease Management component, the Commissioner 
of Inland Revenue determines that a fringe benefit arises and determines that the 
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employee has to be taxed according to the Seventh Schedule of the Income Tax Act42 by 
having the benefit taxed.  
 
The Employment Equity Act43 however determines that the HIV/AIDS testing process 
has to be confidential but the Income Tax Act44 imposes the fringe benefit tax.  
 
The International Labour Organisation (ILO)45 has the following to say of confidentiality, 
continuation of employment relationship and care and support: 
 
 
 
Confidentiality 
‘There is no justification for asking job applicants or workers to disclose HIV-related personal 
information. Nor should co-workers be obliged to reveal such personal information about fellow 
workers. Access to personal data relating to a worker’s HIV status should be bound by the rules of 
confidentiality consistent with the ILO’s code of practice on the protection of workers’ personal data, 
1997’ 
      Continuation of the employment relationship 
‘HIV infection is not a cause for termination of employment. As with many other conditions, persons 
with HIV-related illnesses should be able to work for as long as medically fit in available, appropriate 
work.’ 
 
      Care and support  
‘Solidarity, care and support should guide the response to HIV/AIDS in the world of work. All 
workers, including workers with HIV, are entitled to affordable health services. There should be no 
discrimination against them and their dependants in access to and receipt of benefits from statutory 
social security programmes and occupational schemes.’ 
             ILO Code of Practice on HIV/AIDS and the World of Work, 2001 
 
                                                 
42 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
43 Employment Equity Act 55 of 1998 
44 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
45 ILO Code of Practice on HIV/AIDS in the World of Work, 2001  
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4.  RESEARCH STUDY TOPIC AND METHODOLOGY 
Topic: Fringe Benefits Tax on HIV/AIDS Disease Management of Employees in the 
World of Work  
The purpose of the research study topic would be to, to find a possible solution to the 
problem as stated, by: 
1. Analysing the definition of taxable benefit (section 7 below of this article) by looking 
at the Seventh Schedule and paragraph ( c) of the Gross Income definition of the 
Income Tax Act46  
2. Analysing the protection of rights of employees (section 8 below of this article) in 
terms of the Employment Equity Act47  
3. Investigating opinions by business leaders (section 9 below of this article) in terms of 
possible solutions: 
a. Business Unit South Africa (BUSA) 
i. Paragraph 10(2) c of the Seventh Schedule to the Income Tax 
Act48 
ii. Addition of a sub-paragraph 10(3) or a new paragraph 10B49 
iii. Section 18(1) deduction and Paragraph 11B (4) of the Fourth 
Schedule50 
b. British American Tobacco South Africa (BATSA)  
i. The establishment of a Public Benefit Organisation (PBO), in 
terms of section 3051  
ii. Considering whether the Income Tax Act52 is in conflict with the 
South African Constitution 
iii. Considering a Benefit fund versus the law in terms of Insurance 
and Medical funds or schemes. 
                                                 
46 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
47 Employment Equity Act 55 of 1998     
48 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
49 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
50 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
51 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
52 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
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iv. No taxable benefit for employees if the employer does not seek to 
deduct the Disease Management expenses for Income tax 
purposes.  
v. Considering Cell Captive Insurance as an option 
4. Look at tax relief measures proposed by business leaders (section 9 below of this 
article)  and other vehicles that could possibly fund the Disease Management 
component:  
a. Adapting existing initiatives: 
i. Amendment of paragraph 10(2) c of the Income Tax Act53  
ii. Paragraph 12A of the Income Tax Act 54  
iii. A limited outsourced payroll 
b. Proposing new initiatives 
i. Section 25B and section 30 of the Income Tax Act55 in terms of 
donations and distributions from Trusts. 
ii. Paragraph 12(A) (2)56  as a mechanism to calculate the taxable 
benefit in the hands of all employees as interpreted as a deemed 
taxable benefit according to paragraph 16(1) of the Seventh 
Schedule  
 
 
 
 
 
 
                                                 
53 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
54 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
55 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
56 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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5.  PROBLEM STATEMENT AND MOTIVATION 
The problem to be addressed in industry is that employers need to know how: 
a. To maintain the anonymity of employees in terms of the South African 
Constitution and the Employment Equity Act57 in terms of their 
HIV/AIDS status. 
b. To obtain the optimum tax benefit for the employer and employees 
c. To address the perceived conflict between the Income Tax Act 58 and the 
Employment Equity Act59. 
The HIV/AIDS Disease Management or treatment programmes provided by employers 
are seen as a crucial element in combating the adverse effects of the AIDS caused by the 
HIV contracted due to social and economic reasons (section 2 above of this article).  
An employer can make a serious contribution by augmenting an employee’s income by 
offering to pay for the medical services associated with Anti- Retroviral (ARV) therapy. 
These services can be given from clinics situated at the World of Work or through 
independent organisations that manage the HIV/AIDS World of Work programmes on 
behalf of the employers.  
Government through the Department of Health60 recognises the role of the employers and 
as such endorses a guideline document to be used in the World of Work. The 
Employment Equity Act 61 recognises the employees’ right to confidentiality and 
prescribes procedures for Counselling and Treatment and specifies that the process has to 
be voluntary and hence the term VCT for the Voluntary Counselling and Testing 
programmes conducted in the World of Work.  
                                                 
57  Employment Equity Act 55 of 1998 
58  Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003   
59  Employment Equity Act 55 of 1998 
60  National HIV and Syphilis Antenatal Sero-prevalence Survey in South Africa: 2002 report 
61  Employment Equity Act 55 of 1998 
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The adverse interpretation of the Seventh Schedule of the Income Tax Act62 in terms of 
the HIV/AIDS Disease Management benefit, results in a breech of confidentiality and 
possible resultant discrimination of the employees in the World of Work. In order to 
comply with the Income Tax Act 63 the employees’ HIV/AIDS status have to be known 
in order for Human Resource Management to affect the necessary fringe benefit effect on 
their Income Tax certificate, the IRP5. The South African Revenue Services (SARS) had 
made a statement in public that in terms of their secrecy regulations the confidentiality of 
the employees will be safe. It however still means that employees in the Human Resource 
Departments of the respective employers need to be sworn to secrecy in order to comply 
with SARS’ regulations. Suggestions such as an outsourced payroll have been made but it 
would still mean that the employers need to keep records of the IRP5’s and maintain 
responsibility for the deduction of PAYE and maintenance of records in terms of the 
Income Tax Act 64 and Companies Act, 1974 and Close Corporations Act 1984 and 
therefore the confidentiality as suggested in the Employment Equity Act 65 stays in 
breech.  
The cost of Anti-Retroviral Drug therapy and Disease Management can be very severe 
and most employees will not be in a position to pay between R8 50066 and R33 60067 a 
year for treatment. The company in order to secure its human capital supplies the 
necessary treatment via some Disease Management programme that it pays for as part of 
their general deductions for Income Tax. The Commissioner of Inland Revenue through 
the implementation of the Seventh Schedule of the Income Tax Act68 imposes PAYE on 
the benefit. A blue-collar worker earning say R30 000 a year will pay no Income Tax in 
the 2005 tax year. The treatment of say R30 000 will constitute a fringe benefit of       
R10 000 according to paragraph 2(i)69 and R30 000 according to paragraph 2(e) and 
                                                 
62  Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
63 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003   
64 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
65 Employment Equity Act 55 of 1998 
66 Aid for Aids,  NUMSA, volume 3 nr 2, July 2004, Employers trip on the Receiver’s carpet 
67 Du Plessis J A South Africa, 20 January 2003, countdown to 2010: Management Briefing 
68 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
69 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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2(h)70 and hence will attract tax in the form of PAYE of R116.67 per month on the 
additional R10 000 per year, constituting an increase in spending of 4.67% per month for 
employees with a medical aid, according to paragraph 2(i)71 and three times more for 
employees without a medical aid as they will be taxed according to paragraph 2(e)72. As 
salaries differ in an organisation and tax increases on a sliding scale, the impact of the 
benefit will compound for the lower to medium income earners. 
The deduction of PAYE is easy to calculate but the impact on the individual of making an 
HIV status known in the WOW in terms of discrimination and stigmatisation is 
immeasurable. 
A happy medium should therefore be found to maintain anonymity and the lowest tax 
benefit for the individual when the employer is prepared to not only pay for VCT and 
Education and Training of HIV/AIDS in the work place, but is also prepared to pay for 
HIV/AIDS Disease Management outside of the work place or “off-site”.  
 
6.  RESEARCH STUDY LIMITATIONS 
The study is limited to South Africa and no opinion will be given on International 
practice.  
It is also limited to the interpretation of The Income Tax Act 58 of 1962, as amended at 
the last Revenue Laws Amendment Act 45 of 2003. 
 
 
 
 
 
                                                 
70 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
71 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
72 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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7.  TAXABLE BENEFIT DEFINITION 
 
The Income Tax Act 73 poses a threat to employers and employees alike in terms of the 
deductibility of HIV/AIDS treatment or Disease Management “off-site”; where the 
deduction for the employer can be disallowed as excessive expenditure in terms of 
excessive payments of remuneration and the interest paid component if a bank overdraft 
is used to finance the cost of the taxable benefit.  
 
In turn in terms of the employees, a taxable benefit could be recognised in terms of 
paragraph ( c) of the gross income definition for benefits received in cash or cash 
equivalents or in terms of the Seventh Schedule of the Income Tax Act 74 for the benefits 
derived from HIV/AIDS Disease Management programmes offered by the employer “off-
site”. 
 
The taxable benefit in the hands of the employee can be a full taxable benefit in terms of: 
 “cheap services” paragraph 2 (e)75,  
 payment of debts as described by paragraph 2(h)76 or 
 in terms of paragraph 2(i)77 that of a medical benefit.  
 
In order to satisfy paragraph 2(i) the contribution needs to be made to a medical fund and 
for employees that have Standard Income Tax for Employees (SITE) deducted from their 
remuneration the payment has to be adjusted on a monthly basis. This is to correctly 
calculate the taxable income from which SITE is deducted in order for SITE to be 
correctly calculated once the employees’ IRP 5 certificates are issued. The treatment of a 
medical benefit is more beneficial for an employee as one third of the benefit is taxable 
and two thirds of the benefit is exempt.  
 
                                                 
73 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
74 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003   
75 Seventh Schedule Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
76 Seventh Schedule Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
77 Seventh Schedule Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
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A taxable benefit does not only exist for the employees’ individual benefit but also in 
terms of redirected expenses e.g. when a spouse or child or other person receives a 
benefit by virtue of the employee’s employment. The employee will be taxed on the 
benefit, according to paragraph (i) of the definition of the term ‘gross income’.78 
 
This article will therefore scrutinise the Income Tax Act in terms of paragraph ( c) of the 
gross income definition, excessive remuneration and focus in particular on the taxable 
benefits described in the Seventh Schedule79. 
 
a) Gross Income definition 
 
Paragraph ( c) of the Income Tax Act 80 determines that there must be included in a 
person’s gross income in any year or period of assessment81, any amount, including a 
voluntary award, received or accrued in respect of services rendered or to be rendered or 
any amount received or accrued in respect of or even by virtue of any employment or the 
holding of an office, other than an amount referred to in section 8(1) (allowances or 
advances to employees or office holders).  
 
Excluded from the outline of paragraph (c) is any benefit or advantage to which 
paragraph (i) of the definition applies, that is specifically any fringe benefit taxable in the 
hands of the individual in terms of the Seventh Schedule (paragraph (c)(i)). The general 
definition of  ‘gross income’ relates specifically to amounts ‘in cash or otherwise’, it is 
therefore understood that any reward for services in a form other than cash escaping 
inclusion under the Seventh Schedule could still be taxable under paragraph (c) of the 
definition of gross income.  
 
 
 
                                                 
78 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
79 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
80 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
81 Silke on South African Income Tax, 2004,  (electronic copy) 
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b) Excessive remuneration 
 
The policy of SARS82 is to challenge amounts paid as excessive only when such amounts 
reflect relatively large increases in comparison with amounts charged in previous years. 
If an employer therefore embarks on a Voluntary Counselling and Testing programme 
(VCT) as well as pay for the Disease Management for the employees “off-site”; the VCT 
would be seen as a fresh expense in year 1 and would be scrutinised in terms of section 
11 (a) of the Income Tax Act83 the next year.  
 
If Disease Management were to be included in remuneration and it results in a substantial 
increase in the remuneration expense of the employer from one year to another it can be 
interpreted as an excessive increase and the South African Revenue Service (SARS) may 
want to disallow the expense for the company despite the fact that the employee had paid 
fringe benefit tax. SARS will further look at particular employees on the payroll to see 
whether their salaries are not excessive.  
 
In the example of the blue-collar worker that earns a market related salary of say 
R30 000, he now effectively earns R60 000, and can be taxed in three different ways as a 
taxable benefit: 
 If he has a medical aid, R40 000 will be exempt and R20 000 taxable in his hands 
making his taxable income taxable R50 000 in terms of paragraph 2(i)84 
 R60 000 in terms of “cheap services paragraph 2 (e)85”  
 R60 000 in terms of payments of employee debts according to paragraph 2(h)86.  
 
The affected and infected employee now no longer earns a market related salary and the 
salary could be seen as excessive!  
 
In one case87 it was said in the Special Court that: 
                                                 
82 Silke on South African Income Tax, 2004,  (electronic copy) 
83 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
84 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
85 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
86 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
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“Now, when it is said that remuneration is excessive, and accordingly must be regarded 
as not expended in the production of the income, this court, in determining the question 
under s 11(2)(a) is not exercising discretionary powers, nor must it necessarily look to 
the direct effect of the remuneration which is said to be excessive. Accordingly, when it is 
sought to rule out remuneration under s 11(2)(a) it would seem that the considerations 
that should influence the court would be – (a) that the remuneration is so grossly 
excessive that it could not possibly be regarded in its total amount as producing income, 
and (b) that it had been awarded from some ulterior motive, such as, for example, tax 
evasion or favouritism or the like. For apart from such motives, any award, however 
high, only results in the liability for tax being transferred from the shoulders of one 
taxpayer to another.” 
 
From this court case it can be construed that SARS could see the benefit deducted by the 
employer to secure his human capital in order to secure its survival and improve its 
production by paying for a Disease Management programme as excessive and can 
disallow the expense for the company.   
 
As justification for the excessive remuneration one can look at a number of court cases 
where the Special Court88 had to decide whether alleged excessive remuneration was in 
fact in the production of income. The court took into account various factors such as the 
particular value or the nature of the services rendered, the nature of the business, the 
relationship between the employer and the employee. Another factor looked at was 
whether the amount of the remuneration in relation to the net profit earned by the 
employer was realistic and the dependence of the remuneration paid on the profits earned.  
 
From some of these Special Court cases quite a strong argument can be formulated where 
despite the fact that the net profit in relation to the remuneration paid may not be in line 
in a particular year, the pro-active intervention of a Disease Management programme will 
                                                                                                                                                 
87 ITC 569 (1944) 
88 ITC 335 (1935), ITC 345 (1935), ITC 348 (1936), ITC 397 (1937), ITC 428 (1938), ITC 473 (1940), ITC 
502 (1941), ITC 577 (1944), ITC 610 (1945),  
Verrinder Ltd vs. CIR 1949 (2) SA 147(T), ITC 781 (1953), ITC 1214 (1974),  
ITC 1518 (1989), ITC 1530 (1990) 
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secure the net profit of the company in ensuing years. Another argument would be the 
converse in that due to increased morbidity and mortality the net profit of the company is 
decreasing and therefore it is imperative to spend excessive amounts on remuneration. 
 
The Commissioner of Inland Revenue normally, before objection, then disallows a 
portion of remuneration, interest or rental payable by a company to its shareholders as 
being excessive and not incurred in the production of income. The rationale for an 
apportionment of say interest paid as a deduction is that the interest paid on an overdraft 
facility to finance the excessive expense is not in the production of income. It is SARS’s 
practice to subject the recipient of the benefit to tax on the full amount received as an 
amount in respect of services rendered. This does not make sense because any particular 
amount disallowed as a deduction should not be taxable in the hands of the recipient 
according to case law89. It has been held that a recipient of salary or remuneration is not 
entitled to claim that his assessment should be reduced, on the grounds that his services 
are not worth the whole of the remuneration received90. From this last reported case the 
employer stands a chance of losing the tax deduction of excessive remuneration and 
possible excessive interest paid but the employee will still be taxed on the benefit in 
terms of the Seventh Schedule91. 
 
c) The Seventh Schedule 
 
The Seventh Schedule to the Income Tax Act 92 determines the actual amount to be 
included in the gross income of a person for the year or period of assessment. This 
amount includes the cash equivalent, of the value during the year of assessment of a 
benefit or advantage granted in respect of employment or in respect of the holding of an 
office that is a taxable benefit as defined in that Schedule.  
 
                                                 
89 W F Johnstone and Co Ltd v CIR 1951 (2)  SA 283 (A) 
90 Director v COT 1949 (2) SA 751 (SR) 
91 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
92 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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Paragraph 2 deems a taxable benefit to an employee by his employer in respect of the 
“…a taxable benefit shall be deemed to have been granted by an employer to his 
employee in respect of the employee’s employment with the employer if, as a benefit or 
advantage of or by virtue of such employment or as a reward for services rendered or to 
be rendered by the employee to the employer, certain types of fringe benefits are 
bestowed upon the employee”. This deeming of a taxable benefit applies to the Seventh 
Schedule93 and of paragraph (i) of the definition of the term ‘gross income’ in section 1.  
 
No liability for tax can arise under the Seventh Schedule94 unless the necessary, causal 
link with services required by paragraph 2 is present. The fringe benefit that the 
employee benefits from must also be in the following manner  
• As a benefit or advantage of the said employment 
• By virtue of the employment or 
• As a reward for services rendered or to be rendered by the employee to the 
employer. 
 
It therefore follows that for a tax liability to exist under the Seventh Schedule95 there 
must be an employment contract between an employer and an employee. An ‘employer’ 
is defined as a person who is an ‘employer’ as defined in paragraph 1 of the Fourth 
Schedule96. 
 
An ‘employee’ is defined in paragraph 1 of the Seventh Schedule in relation to an 
employer. An ‘employee’ is primarily defined as a person who is an employee in relation 
to a particular employer for the purposes of the Fourth Schedule97 and as a consequence 
receives remuneration and where the employer deducts employee’s tax from the 
remuneration. 
 
                                                 
93 Silke on South African Income Tax, 2004, (electronic copy) 
94 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
95 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
96 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
97 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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The Income Tax Act98 expands the definition of employer to include an associated 
institution. This associated institution is any other company managed or controlled by 
substantially the same people who manage the employer’s company.  The benefits 
derived from funds 99 set up by the employer or an associated institution, where the 
benefits of the funds are made available for the benefit of employees, former employees 
or family of deceased employees or distributed to these individuals, also fall in the ambit 
of the definition of employment benefits. The benefits are taxable in the hands of the 
employee who enjoys the benefit. This also applies to the heir of the deceased employee 
or the spouse or the retired employee.  
 
A taxable benefit is therefore deemed to be taxed or is taxed in the hands of the employee 
according to the Seventh Schedule100 but there is also a further safety net for SARS in the 
Income Tax Act101  in that the benefit that the employees receive can also be taxed in the 
employees’ hands in terms of the definition of gross income if the benefit was received in 
cash. 
 
The Seventh Schedule102 further obliges the employer to make the necessary tax 
deduction from the employees’ remuneration but SARS has the right to redetermine the 
amount once the employee is assessed in terms of Income Tax. All employees are not 
registered for Income Tax and predominantly pay SITE and as the Seventh Schedule 
obliges the employer to deduct the correct employees’ tax it follows that the employer 
could possibly be held liable by SARS if an audit of the payroll were to be conducted by 
SARS. The author’s experience is that SARS’s practice is to conduct payroll audits and 
as such levy penalties for non submission of PAYE/SITE and section 89(quat) interest on 
underpayment of PAYE/SITE to the employer.  
 
“When an amount of provisional tax, penalty or additional tax payable in terms of the 
Fourth Schedule and an amount of interest payable in terms of s 89bis… becomes due or 
                                                 
98 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
99 Silke on South African Income Tax, 2004, (electronic copy) 
100 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
101 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
102 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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is payable, it will be deemed to be a debt due to the state and may be recovered by the 
Commissioner in the manner prescribed in s 91 … for the recovery of tax and interest due 
or payable under the Act (para 31 of the Fourth Schedule). No reference is made in this 
provision to the interest payable under s 89quat …, but s 91 itself makes provision for the 
recovery of this interest.”103 
 
The employee however has a right to request a directive from SARS if he were to be 
unsatisfied about the amount of the cash equivalent included in his gross income. 
 
The employer must prepare and furnish ‘fringe-benefit certificates’ 30 days after the end 
of a year or period of assessment during which the employee has enjoyed a taxable 
benefit granted to him by the employer (paragraph 14 Fourth Schedule)104. The certificate 
must show the nature of the taxable benefit and the full cash equivalent of its value 
during the year or period.  The employer, within the same thirty-days, must also deliver a 
copy of this fringe-benefit certificate to the Commissioner of Inland Revenue for the 
period or authorised extended period105. An onerous penalty is imposed on the employer 
by SARS of 10% of the cash equivalent of the employee. 
  
The taxable benefit or cash equivalent in terms of Disease Management would be in 
terms of paragraph 2(e) “cheap services” or paragraph 2(h) “payment of employee’s 
debts” of the Seventh Schedule106. It arises when the employer pays for a service 
rendered to the employee by the employer or by any other person and that service has 
been utilised by the employee for his private or domestic purposes either for no 
consideration or for a consideration less than the amount of the ‘lowest fare’ referred to  
in paragraph 10(1)(a)107 or less than the cost referred to in paragraph 10(1)(b)108.  
 
                                                 
103 Silke on South African Income Tax, 2004,  (electronic copy) 
104 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
105 Paragraph 17(3) Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 
45 of 2003  
106 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
107 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
108 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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The cash equivalent of the value of a taxable benefit derived from the rendering to the 
employee of such a service will be fixed under either the ‘lowest-fare’ or the ‘cost’ 
method: 
• Services rendered by an employer to his employees at their place of work for the 
better performance of their duties. 
• Services rendered by an employer to his employees at their place of work as a 
benefit to be enjoyed by them at that place. 
 
Employees’ tax must be deducted from the full cash equivalent of the value of the taxable 
benefit enjoyed by an employee and the amount of this cash equivalent must be reflected 
on the employee’s tax certificate. The employees’ tax must be deducted in the month in 
which the benefit accrues to the employee, unless the deduction is excessive in relation to 
his remuneration for that month, in which event the deduction of tax may be spread over 
the balance of the year of assessment during which the benefit accrued. 
 
In the example of an annual salary for a blue-collar worker of R30 000 per year with 
Disease Management of R30 000; the employee would therefore be taxed at a full  
R60000 per year unless it is funded as a medical benefit where under these circumstances 
only one third of the benefit109 is taxable in the hands of the employee.   
 
Furthermore where an employer contributes a lump sum in respect of all or a class of 
employees ‘in such a manner that an appropriate portion thereof cannot be attributed to’ 
the relevant employee or his dependants, the excess contribution (the taxable benefit) is 
apportioned equally amongst the employees in accordance with the formula depicted in 
paragraph 12A (2)110 akin to a medical fund contribution. If the Commissioner of Inland 
Revenue is not satisfied that this formula is a fair representation of apportionment, he 
may use his discretionary powers to tax it differently.  
 
                                                 
109 Paragraph 2(i), Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 
45 of 2003 
110 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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In conclusion the Income Tax Act111 therefore poses a threat to an employer in terms of 
deductibility of Disease Management in terms of excessive remuneration or in terms of 
an apportionment of interest paid on overdraft to finance the expense. 
 
Furthermore in terms of the employee the Seventh Schedule112 sanctions the employer to 
deduct PAYE from the employee’s income for the taxable benefit enjoyed if the 
employer pays for Disease Management. Paragraph ( c) of the Gross Income definition113 
imposes a further threat if the employee were to receive a benefit in cash or otherwise for 
the treatment of the disease. 
                                                 
111 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
112 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
113 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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8.  PROTECTION OF EMPLOYEE RIGHTS THROUGH EMPLOYMENT 
EQUITY ACT NO. 55 OF 1998 
 
As a first resort we need to scrutinise the Employment Equity Act114 to determine 
whether this Act is in conflict with the Income Tax Act115 in terms of the confidentiality 
of the employee, specifically with regards to HIV/AIDS treatment.  
The preamble to the Employment Equity Act116 quotes that as a result of apartheid and 
other discriminatory laws and practices disparities exist in the labour market creating 
pronounced disadvantages for certain categories of people. The Employment Equity 
Act117 therefore promotes the constitutional right of equality, eliminates unfair 
discrimination in employment and ensures the implementation of Employment Equity to 
redress the effects of discrimination. 
The preamble to this Act wants to equalise the “pronounced disadvantages for certain 
categories of people”. These categories of people had existed as a result of Apartheid. 
HIV/AIDS is more prevalent amongst Black Females118 the HIV/AIDS disease is 
therefore perceived as 119a disease of the Black or the poor or the disadvantaged. Not only 
is employment encouraged that will alleviate poverty but the employees’ right in terms of 
discrimination also seems to be protected.  
Chapter II on Prohibition of Unfair Discrimination, paragraph 5120, encourages every 
employer to take the necessary steps to promote equal opportunity in the workplace by 
eliminating unfair discrimination in any employment policy or practice. 
                                                 
114 Employment Equity Act 55 of 1998 
115 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
116 Employment Equity Act 55 of 1998 
117 Op cit 
118 National HIV and Syphilis Antenatal Sero-prevalence Survey in South Africa: 2002 report and 
  The Weekend Argus, February 19 2005 (females only) 
119 Cf. DUESBERG, P.H. (1996): Inventing the AIDS Virus, Washington D.C.: Regnery; RASNICK, D. 
Talked with President Thabo Mbeki (2 March 200), http://www.virusmyth.com/aids/news/drtalkmbeki.htm; 
GESHEKTER, C. The Plague that Isn’t: Poverty is Killing Africans, not an alleged AIDS Pandemic, says 
U.S. Policy Adviser, http://www.virusmyth.com/aids/data/cgpoverty.htm 
120Employment Equity Act 55 of 1998 
Stellenbosch University  http://scholar.sun.ac.za
  30
 
 
Paragraph 6(1) of the Employment Equity Act 121 states that “no person may unfairly 
discriminate, directly or indirectly, against an employee, in any employment policy or 
practice, on one or more grounds, including race, gender, sex, pregnancy, marital status, 
family responsibility, ethnic or social origin, colour, sexual orientation, age, disability, 
religion, HIV status, conscience, belief, political opinion, culture, language and birth.” 
The Employment Equity Act stipulates in paragraph 7(2)122 of the Employment Equity 
Act how medical testing of an employee for HIV purposes should be conducted; “Testing 
of an employee to determine that employee's HIV status is prohibited unless such testing 
is determined justifiable by the Labour Court in terms of section 50 (4) of this Act.” 
The Employment Equity Act 123 is in essence a law to combat unfair discrimination and 
promote equal opportunities for previously disadvantaged people. The Act furthermore 
specifies the targeted numbers of previously disadvantaged employees to be given equal 
opportunities in different sectors of the work place. Statistics from UNAIDS124 designate 
HIV/AIDS prevalence in race, gender and age bands. From these statistics the Black 
female seems to be the most vulnerable in terms of HIV infection and a trend in terms of 
gender and race can clearly be seen across the gender and race divide. Companies are 
encouraged to get their internal Employment Equity in line and furthermore laws and 
regulations exist in terms of Black Economic Empowerment (BEE) when dealing with 
suppliers or when a company wants to tender or when tenders are awarded.  
The pressure from Employment Equity or Affirmative Action measures and BEE requires 
that companies have to employ more Black employees and as a result employ more 
vulnerable people. Paragraph 15 of the Employment Equity Act 125divides a whole 
section on Affirmative Action measures to ensure that suitably qualified people from 
designated groups have equal employment opportunities.  
                                                 
121 Employment Equity Act 55 of 1998 
122 Employment Equity Act 55 of 1998 
123 Employment Equity Act 55 of 1998 
124 WHO Epidemiological fact Sheets on HIV/AIDS and Sexually Transmitted Diseases, 2002 update 
125 Employment Equity Act 55 of 1998 125 
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Paragraph 15(2)126 describes measures that the Labour Court can take if an employee has 
been unfairly discriminated against; the Labour Court has the right to make any 
appropriate order that is just and equitable in the circumstances. 
Paragraph 15(4)127  describes the process when the Labour Court declares that the 
medical testing of an employee as contemplated in section 7128 is justifiable, the Labour 
Court may make any order that it considers appropriate and may impose conditions 
relating to—“ 
a. the provision of counselling;  
b. the maintenance of confidentiality;  
c. the period during which the authorisation for any testing applies; and  
d. the category or categories of jobs or employees in respect of which the 
authorisation for testing applies. “ 
The Employment Equity Act129 therefore goes to great lengths to protect employees’ 
rights and Part C paragraph 51 is dedicated to Employees’ rights130. Paragraph 51 (1) 
limits discrimination; “No person may threaten a person by preventing an employee from 
exercising any right conferred by this Act or prejudicing an employee because of past, 
present or anticipated “ 
Paragraph 51(3) dictates that no person may favour, or promise to favour, an employee in 
exchange for that employee not exercising any right conferred by this Act or not 
participating in any proceedings in terms of this Act. 
Paragraph 59 of the Employment Equity Act 131 specifies fines to be imposed on any 
person convicted of an offence. Paragraph 51 (1)132 imposes a limitation on any person 
who discloses any confidential information acquired in the performance of a function in 
                                                 
126 Employment Equity Act 55 of 1998  
127 Employment Equity Act 55 of 1998  
128 Employment Equity Act 55 of 1998 
129 Employment Equity Act 55 of 1998  
130 Employment Equity Act 55 of 1998 
131 Employment Equity Act 55 of 1998 
132 Employment Equity Act 55 of 1998 
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terms of this Act, for instance an Human Resource Manager who knows the HIV/AIDS 
status of an employee by virtue of his function as a manager. As a manager responsible 
for the payroll function who by virtue of his knowledge of the source of the taxable 
benefit discloses the confidential information to another will be in breech of this 
paragraph.  
This section of paragraph 51133 could imply that a Human Resource Manager may not 
divulge confidential information to SARS but then Paragraph 51 (2)134 states that the 
subsection (1) does not apply if the “information  
a. is disclosed to enable a person to perform a function in terms of this Act; or  
b. must be disclosed in terms of this Act, any other law (bold inserted) or an order 
of court.” 
The Employment Equity Act135 seems to be a very severe Act that imposes penalties on 
employers for not complying with the conditions of Act but then paragraph 51(2)(b)136  
sanctions the disclosure of the information to the South African Revenue Services 
(SARS). With the words “any other law” the spirit of the Employment Equity Act137 is 
broken. Is this an oversight or an inferior law? 
The Employment Equity Act138 therefore complies with the Income Tax Act139 in terms 
of the taxation of taxable benefits for employees and has no real say outside of the 
Income Tax Act140. It is in essence in conflict with the International Labour 
Organisation’s (ILO) Code of Practice141 in terms of confidentiality, continuation of the 
employment relationship and care and support.  
                                                 
133 Employment Equity Act 55 of 1998 
134 Employment Equity Act 55 of 1998 
135 Employment Equity Act 55 of 1998 
136 Employment Equity Act 55 of 1998 
137 Employment Equity Act 55 of 1998   
138 Employment Equity Act 55 of 1998 
139 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
140 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003   
141 ILO Code of Practice on HIV/AIDS and the World of Work, 2001 
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It is obvious from the following section that Business Leaders are endeavouring to have 
the Income Tax changed rather than the Employment Equity Act, whereas it would 
probably have been much easier to attempt to change paragraph 51(2) (b) of the 
Employment Equity Act to by adding a third condition by way of section c : “(1) does not 
apply if the information “ 
a. is disclosed to enable a person to perform a function in terms of this Act; or  
b. must be disclosed in terms of this Act, any other law or an order of court, 
c. unless conflict exists between this Act and any other law then this must be 
referred to a higher court”(self inserted proposed change to Employment Equity 
Act). 
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9.  INDUSTRY OPINIONS AND INITIATIVES 
a) Opinions of Business Leaders such as BUSA and SACOB 
HIV/AIDS is seen as a pandemic that affects the employer and employee alike and has a 
higher financial impact on the employer than other chronic diseases such as cancer and 
diseases of the heart. The HIV/AIDS prevalence statistics (section 2 above of this article) 
available gives an indication of the potential prevalence in a company and from 
prevalence rates the potential financial impact on the company can be calculated. 
It is therefore encouraging to see initiatives from business leaders to try and alleviate the 
pandemic by setting up workgroups to change the tax legislation although these 
initiatives should not be seen as the only solution to the behavioural problem surrounding 
HIV/AIDS. 
SACOB or the South African Coalition of Business has a tax committee which has set up 
a workgroup on AIDS to inter alia look at the question of the taxable benefits arising 
from HIV/AIDS Disease Management in the work place. SACOB again forms part of 
Business Unity South Africa or BUSA, along with other organisations such as NAFCOC. 
The BUSA AIDS task team has considered possible options for dealing with the taxable 
benefit arising from HIV/AIDS treatment or Disease Management and the associated 
breech of confidentiality. 
In their opinion “no value is placed on the fringe benefit where services are rendered by 
an employer to employees at their place of work for the better performance of their duties 
or as a benefit to be enjoyed by them at that place. This includes medical services and 
medicines. Thus, employees who benefit from HIV/AIDS treatment on site are not liable 
for fringe benefit tax. Where the same treatment is provided off site, the exemption does 
not apply and the employees in question are subject to tax…”  
The interpretation therefore is that no taxable benefit exists if the Disease Management is 
conducted at the employees’ place of work, “on-site”.  
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BUSA142 however has given Government three proposed changes to the Income Tax 
Act143. As a provisional measure they offer the following options for consideration and as 
a first option considers revising paragraph 10(2)144 to clarify the question of  “on-site” or 
“off-site” treatment: 
Option 1: Paragraph 10(2) of the Seventh Schedule of the Income Tax Act145 “(2) No 
value shall be placed under this paragraph on” to be amended by adding a sub-
paragraph (d) reading:  “(d) any services rendered by an employer to his employee for the 
treatment of HIV/AIDS with which the employee is infected”  
The proposed change of inserting (d) to section 10 (2) exempts the benefit arising as a 
result of HIV/AIDS treatment at the place of work (“on-site”) or from the place of work 
(“off-site”)as the benefit is taxable in paragraph 10(1)(b):146   
Paragraph “10.   (1)  The cash equivalent of the value of any taxable benefit derived from 
the rendering of a service to any employee as contemplated in paragraph 2 (e) shall be—
147, “The cash equivalent of the value of any taxable benefit derived from the rendering of 
a service to any employee as contemplated in paragraph 2 (e) shall be - …(b)  the cost to 
the employer in rendering such as service or having such a service rendered, less the 
amount of any consideration given by the employee in respect of such a service.” 
The motivation for the proposed revision of inserting (d) in paragraph 10(2) is on what is 
provided for in paragraph 10(2) ( c)148.“any services rendered by an employer to his 
employees at their place of work for the better performance of their duties or as a benefit 
to be enjoyed by them at that place or for recreational purposes at that place or a place 
of recreation provided by the employer for the use of his employees in general.” 
                                                 
142 BUSA, 31 August 2004, third draft (not for publication), BUSA AIDS task team, 
143 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
144 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
145 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
146 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
147 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
148 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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The Income Tax Act in paragraph 10(2)(c )149 allows an exemption for: 
 Any service rendered by the employer for the better performance of the employees at 
their place of work (on site) 
 Or recreational purposes 
 Or a place provided for recreational purposes. 
The first portion of paragraph 10(2) (c ) “any services rendered by an employer to his 
employees at their place of work for the better performance of their duties” is sufficient 
to argue that “on-site” HIV/AIDS treatment is exempted and therefore (d) as proposed 
needs to be inserted to allow for HIV/AIDS treatment “off site”.  
 As this paragraph allows for off-site recreation it would be difficult for the legislature to 
argue against the provision of relief for treatment of HIV/AIDS off site by the insertion 
of (d). 
Option 2: As the danger exists that SARS will not allow the taxable benefit other than as 
“cheap services” paragraph 2 (e), and paragraph 2(i) only gives relief in terms of 
employees that belong to a medical aid, BUSA proposes the amendment of paragraph 10 
by adding a sub-paragraph 10(3) or a new paragraph 10B reading: “Where any amount; 
being the cash equivalent as determined under the provisions of paragraph 2(i) and 
paragraph 10(1), of the value of a taxable benefit derived by any taxpayer being medical 
expenses or medical aid contributions paid by the employer on behalf of the employee, 
has been included in such taxpayer’s taxable income in any year of assessment, such 
amount shall for the purposes of section 18 of this Act be deemed to be medical expenses 
or medical contributions paid by the taxpayer” . 
Their motivation for this provision is based on similar deeming provisions in the Income 
Tax Act 150 contained in paragraphs such as in paragraph 11(5) of the Seventh Schedule, 
in terms of loan interest. If the legislature deems expenses such as interest on staff loans, 
taxable in the hands of the employees, these taxable benefits in the form of HIV/AIDS 
                                                 
149 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
150 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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Disease Management received by the employees and interpreted as that of “cheap 
services paragraph 2 (e)”151, can therefore be deemed to be that of medical expenses. 
Their motivation152 being that it is probably fair to say that expenditure to cover medical 
expenses be recognised as such for the purposes of section 18 and that the employee 
derives the benefit in terms of the deduction allowed for in section 18(2) ( c)153, where 
employees who do not belong to a medical fund or have medical aid excesses to pay, are 
allowed to deduct medical expenses to the extent that they exceed 5% of the employee’s 
income before these medical deductions.  
Statistics indicate that an HIV-infected employee will pay between R6 000 and R24 000 
per year for Anti-Retroviral (ARV) medicine currently available in South Africa. In 
addition to the ARV drugs the Disease Management treatment includes the monitoring of 
the employee’s  CD4 count (a guide of the employee’s immunity ( section 1 of this article 
above)) as well as other pathology tests done; which amounts to between R40 and R2 000 
per test.154  An infected individual could therefore incur costs of approximately R33 600 
per year on ARV treatment and blood tests conducted through regular monitoring of the 
disease. 
 
In a discussion paper by Jacqueline Arendse and Magda Turner,155 they look at the 
impact of section 18156 on the cash flow of an individual employee.   
 
The application of Section 18(1)157 deduction above on a hypothetical case158 listed 
below, with the average annual cost of HIV/AIDS treatment or Disease Management of 
about R33 600 per year or R2 800 per month159 and an annual salary for an employee of 
R60 000 and a 7,5% contribution of his salary to a pension fund, the allowable deduction 
                                                 
151 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
152 BUSA, 31 August 2004, third draft (not for publication), BUSA AIDS task team 
153 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
154 Du Plessis J A South Africa, 20 January 2003, countdown to 2010: Management Briefing. 
155 Jacqueline Arendse and Magda Turner, HIV/AIDS in South Africa: is a change of tax policy required? 
SAICA and School for Accountancy, University of Witwatersrand   
156 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
157 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
158 Jacqueline Arendse and Magda Turner, HIV/AIDS in South Africa: is a change of tax policy required? 
SAICA and School for Accountancy, University of Witwatersrand  
159 Du Plessis J A South Africa, 20 January 2003, countdown to 2010: Management Briefing. 
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for medical expenditure can be calculated; the effect of the employees’ tax on his cash 
flow and how by re-determining SITE in terms of paragraph 11B (4) of the Fourth 
Schedule160 some relief will be provided on assessment. The section 18161 deduction is 
available to a SITE-only taxpayer, whose net remuneration, or annual equivalent thereof, 
does not exceed R60 000 per annum (section 5(1A) (b)) of the Income Tax Act162. SARS 
will redetermine the SITE payable if the employer had not allowed for the expense on the 
IRP 5 certificate or the cash flow advantage.  
 
Paragraph 11B (4) of the Fourth Schedule163 empowers the Commissioner of Inland 
Revenue to amend the SITE determination and make the necessary refund of applicable. 
 
DESCRIPTION CALCULATION AMOUNT PER MONTH 
Salary  R60 000 R5 000 
Less: Pension contribution (R60 000 * 7,5%) (4 500) (375) 
Subject to employee’s tax  R55 500 R4 625 
Normal tax liability  (6 215) (518) 
After tax income  R49 285 R4 107 
Cash flow after medical expenses R4 107 – 2 800  R1 307 
    
Re-determination of SITE: At the end of the tax year:   
Salary  R60 000 R5 000 
Less: Pension (R60 000 * 7,5%) (4 500) (375) 
  R55 500 R4 625 
Less: Medical expenditure R33 600 - (55 500 * 5%) (30 825) (2 569) 
Taxable Income  R24 675 R2 056 
                                                 
160 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
161 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
162 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
163 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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Tax per tables  (R24 675 * 18%) R4 442 R370 
Less: Primary rebate  (4 860)  
Less: SITE paid  (6 215)  
Refund limited to SITE  R6 215  
Source: Jacqueline Arendse and Magda Turner, HIV/AIDS in South Africa: is a change of tax policy 
required? SAICA and School for Accountancy, University of Witwatersrand   
 
The authors164 mentioned above have a further view to what BUSA had proposed in that 
the 5% reduction of medical expenditure calculated on the taxpayer’s taxable income as 
determined before the deduction as unfair and the application of section 18 on persons 
suffering from HIV/AIDS should be reviewed.  
BUSA165 proposes an option 3, because by proposing option 2, feels that option 2 offers a 
technical solution but with profound repercussions. It can result in a double deduction of 
expenditure as the employee would be allowed to claim the excess of 5% of his taxable 
income contributed as a deduction in his Income Tax return and the employer will be 
allowed the deduction. BUSA166 through some simulations arrive at a conclusion in 
option 3 by proposing that the employer adds back approximately 25% of his total outlay 
on HIV/AIDS Disease Management benefits as a deduction if the employee were to 
afford himself of this option.  Their assumption assumes that an employee with a taxable 
benefit of R20 000 would pay R1 441 in tax and would therefore get the corresponding 
Section 18167 deduction. Adding back 25% will result in the company forfeiting R1 500 
in Income Tax calculated at the company tax rate of 30%.  
 
 
 
                                                 
164 Jacqueline Arendse and Magda Turner, HIV/AIDS in South Africa: is a change of tax policy required? 
SAICA and School for Accountancy, University of Witwatersrand   
165 BUSA, 31 August 2004, third draft (not for publication), BUSA AIDS task team 
166 Op cit 
167 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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b) Initiatives of British American Tobacco (South Africa) BATSA 
BATSA168, as a corporate private company, like other private and public companies, 
wishes to provide ARV treatment to employees free of charge and at the same time 
maintain anonymity of employees’ HIV status and obtain the maximum tax benefit for 
BATSA and the employees. 
BATSA169 recognises the following in the Income Tax Act170:  
 In terms of paragraph 2(h) of the Seventh Schedule of the Income Tax Act171  the 
payment of employees debts including that of medical expenses, paragraph 2 (i) will 
be taxed as a taxable benefit in the hands of the employees and as such must be 
included on the IRP 5 certificate of the employees and as such breeches the 
employees’ confidentiality in terms of their HIV/AIDS status. 
 In terms of paragraph 2(e) of the Seventh Schedule to the Income Tax Act 172 any 
service rendered at the expense of the employer will be rendered as a taxable benefit 
or fringe benefit in the hands of the employee. Once again the benefit has to be 
disclosed on the employees’ IRP 5 certificates and their HIV confidentiality is in 
breech. 
 Paragraph 10(2) ( c)173 offers tax relief in that no value will be placed on any services 
rendered by an employer to his employee at their place of work for the better 
performance of their duties. An opinion was sought by BATSA174 from PWC175 who 
considers that there are reasonable grounds for demonstrating that the provision of 
on-site medical treatment (including HIV treatment) for the benefit of all employees 
is directly related to the better performance of their duties. PWC176recommends that a 
                                                 
168 British American Tobacco South Africa, 4 November 2003, AIDS benefit – Tax 
169 British American Tobacco South Africa, 4 November 2003, AIDS benefit – Tax  
170 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
171 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
172 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
173 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
174 British American Tobacco South Africa, 4 November 2003, AIDS benefit – Tax 
175 PriceWaterhouseCoopers, 11 September 2003,Opinion on HIV/AIDS Treatment and Fringe Benefits 
Tax 
176 PriceWaterhouseCoopers, 11 September 2003,Opinion on HIV/AIDS Treatment and Fringe Benefits 
Tax 
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ruling be sought from SARS confirming the interpretation. On-site medical treatment 
may not necessarily solve the confidentiality issue as other employees or colleagues 
may observe the HIV infected employees visiting the on-site clinics for regular 
treatment. 
 In terms of paragraph 12A of the Income Tax Act177, contributions or payments to a 
registered medical aid fund by an employer on behalf of an employee are taxable in 
the hands of the employee to the fact that it exceeds two-thirds of the total amount 
due. This paragraph is generally applied to monthly payments to a medical aid fund 
and as such if the HIV/AIDS treatment is considered to be a contribution to a fund 
would limit the taxable benefit taxed in the hands of the employees as to one third 
instead of the full benefit. 
BATSA therefore sought opinions from tax experts, has representation on the AIDS 
committee of BUSA, had asked for opinions from experts such as PWC, for solutions to 
minimize the tax on employee benefits and try and preserve the anonymity of the 
employees’ HIV/AIDS status :  
 The establishment of a Public Benefit Organisation (PBO), in terms of section 30 of 
the Income Tax Act178. The Ninth schedule179 lists those activities that are accepted as 
Public Benefit activities; paragraph 2 under the heading “Health Care” lists paragraph 
2 ( c) “ the prevention of HIV infection, provision of preventative and education 
programmes relating to HIV/AIDS” and paragraph 2(d) includes “the care and 
counselling or treatment of persons afflicted by HIV/AIDS”. It also allows for the care 
of families and dependants. However, in terms of the definition of a Public Benefit 
Organisation as amended; the benefits of the fund must be applied as widely as 
possible and must be accessible to the general public at large.  
Claire van Zuylen and Betsie Strydom of Bowman Gilfillan180support the idea of a 
Public Benefit Organisation in the form of a trust, where the trust receives the 
                                                 
177 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
178 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
179 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
180 M Metcalfe, October 2004, How can I support Africa? The Foundation for the development of Africa,  
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subsidised payment from the Employer or Associated Institution to provide the 
HIV/AIDS benefits. The Public Benefit Organisation status exempts the trust from 
income tax on income received in the form of donations.  
SARS however interprets the section 30 of the Income Tax Act181 in that a public 
benefit activity must be rendered for the benefit of the public at large, which 
unfortunately excludes a company's HIV/AIDS programme to their employees 
because “general public at large” definition seems to be that of any member of society 
at large that is not necessarily an employee.  
 Due consideration was given whether the Income Tax Act182 was in conflict with 
the South African Constitution, but it was decided not to pursue this avenue. 
 The option of a Benefit fund was also considered but the advice of PWC183 was that 
due consideration has first got to be given to the provisions of the law in terms of 
Insurance and Medical funds or schemes. 
 Another option was to suggest to SARS that, provided the employer does not 
deduct the expense the employees will not receive a taxable benefit. SARS 
confirmed that there was no provision in the Income Tax Act 184 to give them the 
discretion to come to such an arrangement   
 BATSA185 considered making use of Cell Captives as a solution, in that funds are 
transferred to its cell captive facility in an insurance company where BATSA is the 
insured. As a short term insurance measure the policy could typically cover the cost 
associated with HIV/AIDS. Premiums are renewable and payable annually. The 
premium could be based on the estimated cost of the HIV/AIDS intervention and an 
estimate can be made based on the estimated HIV/AIDS prevalence amongst the 
employees and their spouses or life partners. An opinion from PWC186 was not very 
positive as in their opinion it can be construed as a debt paid on behalf of the 
                                                 
181  Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
182 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
183 PriceWaterhouseCoopers, 11 September 2003,Opinion on HIV/AIDS Treatment and Fringe Benefits 
Tax 
184 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003   
185 British American Tobacco South Africa, 4 November 2003, AIDS benefit – Tax 
186 PriceWaterhouseCoopers, 11 September 2003,Opinion on HIV/AIDS Treatment and Fringe Benefits 
Tax 
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employees by BATSA and therefore the cell captive could be perceived merely as a 
finance vehicle187. PWC’s opinion can be interpreted as too conservative as BATSA 
will be insuring itself against the risk of AIDS and BATSA derives the benefit.  
Another option was considered where cell captives are used and instead of BATSA 
the employer being the insured, the employee is the insured. An opinion from 
PWC’s188 was positive in that an arrangement where the employee is the insured 
would not be construed as a payment of debts of employees. However, from a 
practical point of view the employees’ pro-rata share from the premium is payable to 
the employee and may not be ceded to BATSA or a third party, such as a Disease 
Management entity (e.g. QUALSA). This option is therefore not considered as 
BATSA has no control over what the employees do with the money once the 
insurance benefits are received by the employee concerned. 
c. Opinions of SARS officials and Corporate Companies 
 NUMSA189 (NATIONAL UNION OF METAL WORKERS OF SOUTH 
AFRICA) 
"We're no longer focusing on wage increases alone," says Numsa spokesman Dumisa 
Ntuli. "Benefits are also important. All aspects of HIV/Aids treatment need to be 
negotiated, including family responsibility and sick leave, as well as medication."  
 DE BEERS190 MINING HOUSE 
The mining house De Beers wanted to give employees the additional choice of going to 
private doctors to receive treatment and counselling, in addition to its on site medical 
facilities. The HIV/AIDS manager Tracey Peterson found that SARS considers any 
medical treatment provided at an employer's expense outside the company's premises to 
                                                 
187 Paragraph 2(h), Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 
45 of 2003 
188 PriceWaterhouseCoopers, 11 September 2003,Opinion on HIV/AIDS Treatment and Fringe Benefits 
Tax 
189 NUMSA, Employers trip on the Receiver’s carpet, volume 3 nr 2, July 2004 
190 NUMSA, Employers trip on the Receiver’s carpet, volume 3 nr 2, July 2004 
Stellenbosch University  http://scholar.sun.ac.za
  44
 
 
be a fringe benefit and therefore taxable. De Beers has decided to shoulder the cost until 
it can convince Government to change the tax law.  
 Chamber of Mines191 head Zoli Delisa says the tax system has the effect of pushing 
workers into an artificially higher earnings bracket.  
 Aid for Aids192 clinical director Leon Regensberg, in the publication Aids 
Management Report maintains that employers should alter existing employee 
contracts and make medical aid membership compulsory.  It is also Regensberg view 
that the most cost-effective way for uninsured employees to comply with regulations 
is to have a combination of access to medical aids by the employees supplemented by 
Disease Management programmes offered by employers. 
 According to Jillian Green in an article on July 15, 2004 she quotes opinions from 
SARS193 on the provision of treatment by employers as a "fringe benefit". The 
treatment is seen as a benefit and hence taxable according to SARS. 
 SARS194 spokesperson Sechaba Nkosi said: "The income tax system measured such 
contributions against the same standards as employer contributions for provisions of 
other goods and services." Nkosi said that, in terms of confidentiality, SARS was 
bound by strict secrecy provisions and would not disclose the HIV status of an 
employee. 
As far as confidentiality of treatment funded by employers is concerned, Nkosi said 
employers had different approaches. "Some employers take advantage of exclusion in 
the fringe-benefits tax system for medical treatment provided to employees on an 
employer's premises, while some may use external suppliers and pay them on a no-
questions-asked basis." 
 According to Monique Metcalfe in an article published in October 2004, SARS’195 
opinion on the fringe benefit tax for HIV/AIDS treatment is that: "The income tax 
system measured such contributions against the same standards as employer 
                                                 
191 NUMSA, Employers trip on the Receiver’s carpet, volume 3 nr 2, July 2004 
192 NUMSA, Employers trip on the Receiver’s carpet, volume 3 nr 2, July 2004 
193 NUMSA, Employers trip on the Receiver’s carpet, volume 3 nr 2, July 2004 
194 NUMSA, Employers trip on the Receiver’s carpet, volume 3 nr 2, July 2004  
195 Monique Metcalfe, How can I support Africa? October 2004, The foundation for the development of 
Africa 
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contributions for provision of other goods and services". The opinion is therefore that 
SARS or Government does not distinguish between taxable benefits and treat 
HIV/AIDS Disease Management as any other taxable benefit.  The newspaper, The 
Star, quoted SARS spokesman Sechaba Nkosi as saying that companies providing 
such contributions are “up in arms” and have accused the Revenue service of taxing 
their HIV-positive workers to death! 
  SARS196 is of the opinion that if concessions are given for HIV/AIDS in terms of 
taxable benefits the move would have to be extended to all major diseases.  
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
196 Monique Metcalfe, How can I support Africa? October 2004, The foundation for the development of 
Africa  
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10.  POTENTIAL SOLUTIONS TO THE PROBLEM BY INVESTIGATING 
OTHER ALTERNATIVES 
In summary, the problem surrounding HIV/AIDS in the World of Work; is that the 
undetected HIV positive status of employees and resultant untreated AIDS lead to death, 
and therefore individuals need to know their status in order to proactively get the life-
saving Anti-Retroviral treatment that will save the individual’s life, the sex partners’ 
lives, preserve their family lives, social standing and the life of the employer. If 
HIV/AIDS is eradicated a healthy work force results with a healthy or financially secure 
and sustainable company that in turn can give employees job security. A healthy work 
force leads to a healthy company and an economically stable country. 
It is the author’s opinion that there is a general reluctance from individuals to have their   
HIV/AIDS status determined. This might be because of fear of death, fear of the 
unknown, fear of the stigma surrounding the disease, ignorance or generally an attitude of 
“it cannot conceivably happen to me”. There is obviously the factor of financial 
constraints or being uneducated about how to find out more about the disease or what 
avenues are available for treatment. From VCT programmes run by companies such as 
AfriSIDA Management Services (Pty) Ltd employees often believe that they could 
potentially not contract the disease as they trust their sleeping partners in terms of a 
commitment of one sexual partner only. It is only human to only to deduce that when 
morbidity strikes  people go to Medical Practitioners and often too late as the nature of 
the disease is such that it goes undetected until the immune system is worn out and then 
the individual contracts AIDS (section 1 above of this article).   
From business initiatives discussed in this article it is clear that in order to curb morbidity 
and mortality, companies pay for HIV/AIDS Awareness, Training and VCT. However, 
once the employee knows his status, the employee needs some form of treatment; initially 
to determine his CD4 count to determine his level of immunity or stage of infection and 
depending on the progression will need Anti-Retroviral (ARV) treatment. It is here that 
companies supplement the cost of HIV/AIDS treatment and look at Government for tax 
concessions. It is the author’s opinion that the company feels morally more indebted 
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because often the employee gets to know his status through an HIV/AIDS campaign or 
programme in the work place. 
Government has divested themselves from further assistance as it sees the disease as any 
other life threatening disease and as such has given the necessary tax concessions in 
terms of medical benefits and company tax deductions. (Section 10 c above of this article) To 
the employer the concession of a section 11(a) deduction in the Income Tax Act197 is 
afforded. The argument is that it taxes the employee as having received a taxable 
benefit198 in the form of a cheap service, a payment of debts on behalf of the employee or 
a medical benefit where the employee can get a two third benefit through a medical aid. 
But it gives the necessary further tax concessions, like any other life threatening disease,  
to employees by allowing the medical excesses paid by the individual directly to the 
medical aid or medical practitioner  as a deduction according to  Section 18(1) or re-
directed SITE through paragraph 11B (4) of the Fourth Schedule199. Unfortunately no 
consideration is given to the fact that the employee suffers severely from a cash flow 
point of view (section 9 above of this article) as they have to wait more than a year for a tax 
refund on cash expended on ARV treatment from SARS.  
The author and PWC200 are further of the opinion that a further argument in 
Government’s favour is that Government subsidised clinics are available for individuals 
to receive the necessary primary care treatment. Unfortunately the clinics are not 
accessible after hours for employees. If they were to attend these clinics during the day 
they are treated on a “first-come-first-serve” basis and as such means that employees will 
have to take prolonged sick leave or time off work. Questions will be asked by the 
employers about the sick leave and immediately the matter of “confidentiality” or 
anonymity becomes an issue again. Even if Government clinics are an option not all 
                                                 
197 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
198 Paragraphs 2(e), 2(h) and 2 (i) of the Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up 
to and including Act 45 of 2003  
199 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
200 PriceWaterhouseCoopers, Budget 2004, Review of medical aid and HIV-related expenses in the budget, 
Tax and Legal Services  
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employees will attend these clinics due to transport constraints, work pressure etc. or a 
general reluctance to queue.  
There seems to be a definite burden shift from Government to the private sector, as a  
result of Government’s view that the disease should be treated like any other life-
threatening disease, to a situation where the employers have to take responsibility for the 
pandemic. 
Some employers offer to pay for the HIV/AIDS Disease Management as we have seen 
that the cost of ARV treatment can be anything from R8 500 per year to as high as 
R33 600 per year. The employer’s motivation is that with the potential death sentence of 
the employee comes the financial strain of finding a way to foot the medical bills. It is 
therefore the moral obligation and protection of the employer’s human capital that drives 
the company to help foot the bill for the ARV treatment or HIV/AIDS Disease 
Management. It is also imperative from the employer’s point of view that everyone 
knows their HIV/AIDS status and takes responsibility for it 
In the National budget review of 2004 PWC201 reviewed medical aids and HIV related 
expenses; it is their view that because of the unaffordability of medical bills more 
individuals are becoming dependent on Government medical care and assistance. The 
burden on Government or dependency on Government will increase as a result of 
HIV/AIDS. Government is according to them already contributing by way of the Seventh 
Schedule to the Income Tax Act when employees’ medical aid contributions are paid by 
the employer.   
A further factor driving the private sector to find solutions is the fact that Government 
with a perceived dissident view202 or history of allegedly saying that HIV does not cause 
AIDS, poverty does, is now asked to alleviate the problem through tax concessions. No 
                                                 
201 PriceWaterhouseCoopers, Budget 2004, Review of medical aid and HIV-related expenses in the budget, 
Tax and Legal Services  
202 DUESBERG, P.H. (1996): Inventing the AIDS Virus, Washington D.C.: Regnery; RASNICK, D. 
Talked with President Thabo Mbeki (2 March 2000), 
http://www.virusmyth.com/aids/news/drtalkmbeki.htm;  
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wonder a SARS spokesperson makes the statement that the disease is treated like any 
other life-threatening disease, one almost feels that by making such a statement SARS 
supports Government’s view on HIV/AIDS.  
Given that Government is classified as dissidents in terms of HIV and AIDS, the 
Employment Equity Act sanctions the taxable benefit taxation and employers want to 
protect their human capital and employees are not going to change their sexual behaviour 
through abstinence; we will have to find a way to get some further tax relief and protect 
the employees right to confidentiality and anonymity. 
Anglo Gold’s203 Dr Eisenstein observes that HIV/AIDS can only be tackled in an 
environment inducive to do so:  
  
“A challenge for the industry is to ensure that all parties are active partners in this 
process, Business cannot overcome this problem alone and I would rate the absence of 
a national supportive framework as the single biggest challenge in coping with the 
HIV/AIDS epidemic. From the State we need an overall plan that recognises the 
severity of the epidemic, with adequate budgetary allocation in terms of support and 
infrastructure for the people of South Africa” 
 
The following options will therefore be considered: 
a) Adapting Existing Initiatives: 
i) Amendment of Paragraph 10(2)( c) of the Seventh Schedule204 
The direct implications of the taxable benefit is that in terms of paragraph 2(e) of the 
Seventh Schedule to the Income Tax Act 205 any service rendered at the expense of the 
employer will be rendered as a taxable benefit or fringe benefit in the hands of the 
                                                 
203 Financial Mail Corporate AIDS awareness 6 December 2002 
204 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003   
205 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003   
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employee. There is the conception in industry that the taxable benefit only exists once the 
service is “off-site” based on paragraph 10(2) (c) of the Seventh Schedule206, no value 
will be placed on  “.. any service rendered by an employer  to his employees at their 
place of work (self inserted bold) for the better performance of their duties or as a benefit 
to be enjoyed by them at that place (self inserted bold) or for recreational facilities…”. It 
is PWC’s207 view that an opinion must first be sought from SARS but the author tends to 
disagree as the intention of the paragraph is clear in that no value will be placed on a 
service rendered by an employer “on-site” for the better performance of their duties and 
therefore further agrees with Industry’s interpretation. It is not clear why PWC needs an 
opinion from SARS. The proposed changes of the Income Tax Act by BUSA (section 10 a 
above of this article) by the insertion of (d) in paragraph 10(1) is based on the assumption 
that, because recreational facilities are allowed off-site, therefore HIV/AIDS Disease 
Management will be allowed off site and hence probably why PWC wants to seek an 
opinion first.  
An HIV/AIDS Disease Management programme at the place of work or “on-site”, will 
thus be the answer in terms of the exemption of the taxable benefit in terms of section 
10(1) (c )’s first portion, but will definitely not secure anonymity as any employees called 
away from a work station or production lines will attract the attention of co-workers and 
they could be stigmatised and discriminated against as a result of their HIV status 
becoming known. 
The extension of the paragraph 10(2) ( c)208 referring to the recreation facilities provided 
by the employer   “.. for recreational facilities at that place (sic on-site) or a place of 
recreation provided by the employer for the use of employees in general”, “place of 
recreation” should be substituted by “place of recreation or for the benefit of HIV/AIDS 
care not covered under paragraph 2(i) ”. This then would enable the employees to attend 
a clinic or medical practice “off-site” earmarked by the employer as part of an HIV/AIDS 
work place programme. The rationale to include “HIV/AIDS” in the proposed 
                                                 
206 Income Tax Act no. 58 of 1962 as amended up to and including  Act 45 of 2003  
207 PriceWaterhouseCoopers, 11 September 2003, Opinion on HIV/AIDS Treatment and Fringe Benefits 
Tax,  
208 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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amendment would be to secure human capital and extend the life of the employee and 
employer and society as a whole. 
It is important to specify the benefit as it could otherwise be seen as medical care and will 
be taxed according to paragraph 2(i) or 12A.209The Commissioner of Inland Revenue 
might in fact interpret it as such and it is therefore necessary to look at this paragraph in 
more depth to secure the tax relief. 
The changes to this paragraph will result in all employees opting for this option and no 
deductions will be taken through paragraph 2(i)210. This is not a negative aspect as it will 
preserve the benefits in medical aids in general as there will be no pressure on medical 
aids as a result of the pandemic to increase their premiums excessively and thereby 
making it more affordable for employees to subscribe to medical aids. 
ii) Paragraph 12A (1) of the Seventh Schedule211 
The concession for medical aid contributions (paragraph 2(i))212 only relates to 
contributions made towards a Friendly Society and a scheme registered in terms of the 
Medical Schemes Act. Benefits and assistance granted outside of a medical scheme will 
not qualify for the two thirds concession; “…payment to any fund contemplated in 
paragraph (b) of the definition of a benefit fund  ...”. Paragraph (b) of section 1 describes 
“..any medical scheme registered under the provisions of the Medical schemes Act, 1998 
(Act 131 of 1998)”.. 
Paragraph 2(i)213 taxes the contribution to a benefit fund in the hands of an employee to 
the extent that it exceeds two thirds of the total contribution. One third of a medical 
benefit contribution is thus taxable in the hands of the employee as a taxable benefit. Any 
other medical expenses incurred by the employee outside of the medical  aid for example 
excesses paid that are not covered by the medical fund can be deducted from the 
                                                 
209 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
210 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
211 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003   
212 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
213 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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employee’s income once a tax return is remitted at the end of the financial year. This 
deduction is limited to the excess over 5% of income before the deduction of the medical 
benefit in arriving at taxable income. This benefit tend to favour lower income earners 
unless  one assumes that a higher income earner, say earning R250 000 p.a. has personal 
Disease Management expenses of R33 000 then the first R12 500 will not be tax 
deductible. 
As a solution to anonymity it would possibly be a solution to get an external accountant 
or tax practitioner that assists employees with the registration of tax, filling out of tax 
returns or applications for re-direction of SITE (section 9 c above of this article)214 instead of 
relying on the employer’s pay roll clerk or human resource manager. Often the 
employees are uneducated on the complex issues regarding tax and need to be made 
aware of how to interpret the Income Tax Act very much like an Awareness of 
HIV/AIDS. In this instance their anonymity will be secured especially if the service is 
available to all employees for tax matters in general and the consultant is “on-site”. The 
only disadvantages possibly of such an exercise is that their will not be a full tax benefit 
for the employees and their cash flow will be impeded until they get a refund from 
SARS. 
Employing a tax practitioner to assist the employees with their personal tax affairs, will 
result in a further tax benefit to the employees but once again if the service is offered at 
the place of work, the benefit will not be taxable in terms of the first portion of paragraph 
10(1)( c) of the Seventh Schedule.215  
iii) A limited outsourced payroll 
In the absence of a potential change to paragraph 10(2) ( c)216, the HIV/AIDS benefit 
received “off-site” is taxable and as such impacts on the confidentiality of the employees’ 
HIV status as the benefit enjoyed has to be disclosed on an employees’ IRP 5 certificates 
at year end (section 7.c. above of this article).  
                                                 
214 Jacqueline Arendse and Magda Turner, HIV/AIDS in South Africa: is a change of tax policy required? 
SAICA and School for Accountancy, University of Witwatersrand 
215 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
216 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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A potential solution to this could be that the payroll is outsourced and the IRP 5 
certificates are issued by an outside consultant, but that would mean that all employees’ 
payroll records will have to be kept off-site. The repercussions of such an exercise does 
not warrant the outsourcing because not only do the Directors have to take responsibility 
for all accounting records, assets, liabilities, income and expenditure, they also need the 
payroll information for budgeting purposes and other cost and management exercises.  
The responsibility of recordkeeping, tax liabilities etcetera will not be able to be 
delegated to a third party without someone at the employer’s office having access to the 
records and as such an outsourced payroll will not be practical in the light of all statutory 
requirements on Directors and Public Officers. Once an official is earmarked at the work 
place the whole exercise of protection of anonymity is defeated. 
b) New Proposed Initiatives 
i) Section 25B of the Income Tax Act217 in terms of distributions or 
donations from Trusts. 
 
According to the author and SILKE218; a trust in essence is a contract between a settlor, 
trustees and beneficiaries and is defined as consisting of cash or other assets and these 
assets are administered in a fiduciary capacity by a trustee or trustees. The trustees are 
appointed by a deed of trust or agreement and the trust is registered with the Master of 
the High Court. The assets are managed on behalf of the beneficiaries by the trustees. The 
beneficiaries have no right to these assets or income unless so described in the trust deed 
by virtue of vesting rights or in the case of a discretionary trust, unless a benefit is 
bequested by the trustees to the beneficiaries.   
 
In terms of the Income Tax Act the trust is defined as a “person other than companies”219 
and if no distributions are made to beneficiaries the income is taxed at 40%220.  Where a 
                                                 
217 Income Tax Act no. 58 of 1962 as amended up to and including  Act 45 of 2003 
218 Silke on South African Income Tax, 2004, (electronic copy) 
219 Meyerowitz SC, 2003-2004, Meyerowith on Income Tax, Cape Town: The Taxpayer,   
220 Schedule 1, section 8 1(b), Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 
2003  
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trust is created by way of donation, settlement or other disposition (donation) from a 
living person which includes a company, the trust income is governed by the provisions 
stipulated in section 25B and subject to the provisions of section 7221.  
 
Two types of trusts exist, a discretionary trust or inter vivos trust or a vesting trust. An 
Inter Vivos trust can be set-up as a Public Benefit Organisation (PBO) in terms of section 
30222 for the benefit of the employees and their spouses and children, diseased retired or 
ex-employees’ direct family and living partners, provided the funds are also available for 
the general public at large. In order to qualify as a PBO in terms of section 30223 the 
benefits must be available to the “general public at large”.  
 
A Public Benefit Organisation is defined in section 30224 for various benefits to the 
public. These benefits or purposes are defined in the Ninth Schedule225, Part 1, dealing 
specifically with PBO’s. The object of a PBO is to have tax exempt status, and to 
therefore receive donations exempt of tax and apply the donations for the benefit of the 
general public at large. Paragraph 2 (c)226 allows for one such purpose; the prevention of 
HIV infection and the preventative measures by way of educational programmes relating 
to HIV/AIDS. Paragraph 2 (d)227 allows for another such purpose; the care, treatment and 
counselling of persons afflicted with HIV/AIDS, including the same care for their 
families and dependents.  
 
If the Trust is registered as a non-profit organisation or a private benefit organisation the 
receipts from the trust will not be taxable. As the PBO trust has no specific beneficiaries 
listed, but rather makes donations available to a class or classes of beneficiaries these 
donations will be tax free in the hands of the individuals or organisations that benefit as 
the donation will be of a capital nature, because the awards are of a fortuitous nature.  
 
                                                 
221 Income Tax Act no. 58 of 1962 as amended up to and including  Act 45 of 2003 
222 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
223 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
224 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
225 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
226 Ninth Schedule, Part 1, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
227 Ninth Schedule, Part 1, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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It could be argued that Capital Gains Tax should be paid by the Trust in terms of The 
Eight Schedule228 on the donations made to recipients as donations of an asset is seen as a 
disposal in terms of paragraph 11 of the Eighth Schedule. Although 50 % of the capital 
gain relating to such is included in the taxable income of the PBO, the PBO does not pay 
any tax on it as the statutory tax rate applicable to PBO’s is 0%. 
 
The income received by the recipient as a voluntary award, must not be included in his 
gross income in terms of the extension of paragraph (ii)229 of the definition of gross 
income: “..excluding receipts and accruals of a capital nature..”.  Care should be taken 
that the receipts granted by the Trust to the recipients are not received on a regular or 
repetitive basis, because such receipts can be contemplated as an annuity according to 
paragraph (a) of the definition of gross income in section 1, and will then specifically 
included in gross income. 
  
The donor company receives a section 18A exemption certificate for donations received 
by the PBO trust. A deduction for a taxpayer is limited to 5% of taxable income. 
 
If the employer, were to donate funds to the PBO trust as a donation with the intention of 
accommodating  their employees only in terms of HIV/AIDS Disease Management: 
 the PBO’s action will be against the intention of the Income Tax Act230 as it must be 
available to the general public at large and the trust will loose it’s exempt status and 
will then have to pay tax at the prescribed rate.   
 The trust will be an associated institution and a taxable benefit will have to be taxed 
in the recipients’ hands. 
 
A VCT programme conducted by a company such as AfriSIDA identifies the HIV 
positive employees on-site; the employer gets a section 11(a)231 deduction for the VCT 
programme. In terms of Disease Management the employer has the following options: 
                                                 
228 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003  
229 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
230 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
231 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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 Pay for Disease Management and tax the benefit in the hands of the recipient of the 
benefits and the employee suffers as a result of the burden of tax and the stigma 
attached to the fact that his HIV status might be made known to all and sundry 
 Pay for the VCT and get a section 11(a)232 deduction and give a section 18A233 
donation to a PBO registered for HIV/AIDS care with the hope that the employees 
might benefit when applying for grants or donations from the trust.  
 
The funding process could thus be as follows:  
 The PBO trust is managed by the same bona fide HIV/AIDS work place managers 
and Disease Managers employed in the VCT process, the employer can have some 
assurance that his employees could possibly apply to such a fund for a donation to 
pay for the necessary care.  
 The donor employer receives a section 18A donation certificate for tax purposes and  
 a process is then embarked on where the employees are encouraged to apply for 
funding for Disease Management from the PBO Trust.  
 Immediately spouses and live-in partners can also apply for funding.  
 In collaboration with the specific medical aid of the donor company benefits can be 
quantified and managed on behalf of those employees who belong to a medical fund. 
  All other non-medical aid employees apply for full funding from this trust. 
  AfriSIDA approaches the next designated work place for a VCT programme and the 
same process is followed to try and secure Disease Management to employees that 
form part of the “general public at large”  
 and they continue approaching employers  
 and employees and spouses continue applying for funding.  
 
With this solution a situation is created where the anonymity of the “employees’ are 
protected, the benefit is tax free in the hands of the “employee” and the donor employee 
gets a section 18A234 donation deduction limited to a donation free deduction. 
                                                 
232 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
233 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
234 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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However many companies as potential donors to such a PBO, (although administered by 
experts in their fields) would feel that the donations will not benefit their employees and 
their loved ones directly. There could be a general reluctance also from potential donors 
as they could feel that such a fund will have to donate money to institutions that would 
normally qualify for Government funding.  If a PBO is registered as described it will 
have to be well managed, probably audited with results published in the media etcetera 
and marketed as such to get “buy-in” from potential donors in terms of their respective 
Corporate Social Investment Programmes. 
 
ii) Paragraph 12(A) (2)235  as a mechanism to calculate the taxable benefit in the 
hands of all employees as interpreted as a deemed taxable benefit according to 
paragraph 16(1) of the Seventh Schedule  
Business Unit South Africa (BUSA)’s AIDS committee (section 9(a) of this article above) 
seeks to use deeming provisions to drive a change in legislation.  
This section of this article seeks to find a way to tax a benefit in the hands of all 
employees based on the fact that a causal relationship exists between the benefit of 
Disease Management that HIV positive employees receive and the services of each 
employee.  
Paragraphs 2(e), 2(h) and 2(i)236 make it impossible for an employee to have Disease 
Management paid by the employer to a Medical Practitioner, Disease Management 
Company or to supply Anti-retroviral drugs when the Disease Management takes place 
away from the employee’s place of work for the employee, his spouse or other person. It 
will either be taxed as cheap services, debts paid on behalf of an employee or as a 
medical benefit. 
 
                                                 
235 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
236 Seventh Schedule Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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An employee however will be deemed to have been granted a taxable benefit in respect 
of his employment with an employer when certain other persons enjoy a benefit or 
advantage that would have constituted a taxable benefit contemplated in paragraph 2 and 
paragraph 16(1)237 had it been granted directly by the employer to the employee. The 
taxable benefit so deemed to be granted is then treated as if it had in fact been granted to 
the employee, and the provisions of the Seventh Schedule apply to it on this basis. The 
intention of this paragraph is to tax benefits received by spouses or others by virtue of the 
employee’s employment in the hands of the employee. 
 
This paragraph however grants a benefit to the employee or deems a benefit if certain 
other persons also enjoy a benefit, if the employee could have enjoyed it in his own right. 
It could therefore be argued that this interpretation of redirected benefits does not only 
apply to the benefits granted to spouses or children of the employee but also to 
colleagues’238 as paragraph 16(1) provides for a deeming allowance “..an employee shall 
be deemed to have been granted…”. This deeming allowance enjoyed is by virtue of the 
employee’s holding of office or “..services rendered or to be rendered…”. 
 
The benefit conferred upon the employee has to be: 
 As result of a benefit of the employee’s employment with the employer or 
 As an advantage of the employee’s employment with the employer or 
 By virtue of the employee’s employment with the employer 
 
Paragraph 16(1) (b) states therefore that anything done by the employer, under any 
agreement, transaction or arrangement, that confers such a benefit or advantage upon any 
person other than the employee, whether directly or indirectly will be seen as been 
granted directly to the employee.  
 
If the employer therefore stipulates in the employment contract that Disease Management 
is available to all employees and that the total contribution of the Disease Management 
                                                 
237 Seventh Schedule Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
238 Silke on South African Income Tax, 2004,  (electronic copy) 
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will form part of their cost to company on a capitation basis, it will be seen as a benefit 
conferred upon any other person and as such is a taxable benefit in the hands of all the 
employees. 
 
The benefit conferred upon other persons needs to be granted in respect of a specific 
employee’s employment before it can be taxable in that employee’s hands. As such if an 
employer grants a benefit to all employees as a result of their employment and some of 
the employees make use of the benefits and others not and they would only have enjoyed 
the benefit as a result of the specific employment it can be argued that the intention of 
this section on redirected benefits includes colleagues. 
 
“The employer/employee relationship is also expanded in the other direction, that is, on 
the employee’s side, since, for the purposes of the Seventh Schedule and para (i)239 of the 
definition of the term ‘gross income’, an employee will be deemed to have been granted a 
taxable benefit in respect of his employment with an employer when certain other 
persons enjoy a benefit or advantage that would have constituted a taxable benefit 
(bold inserted) contemplated in para 2 had it been granted directly by the employer to the 
employee. This result will ensue if, as a benefit or advantage of his employment with his 
employer, by virtue of his employment with his employer or as a reward for services 
rendered or to be rendered by him 
• the employer has directly or indirectly granted a benefit or advantage to the 
employee’s relative or 
• anything is done by the employer under an agreement, a transaction or an 
arrangement so as directly or indirectly to confer any benefit or advantage upon any 
person other than the employee (bold inserted).” 240 
 
The taxable benefit so deemed to be granted is then treated as if it had in fact been 
granted to the employee, and the provisions of the Seventh Schedule apply to it on this 
basis.241 
                                                 
239 Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
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In order to argue that a taxable benefit exists in the hands of all employees, if the benefit 
is available to all employees, the definition of causal relationship between the employees’ 
employment or services and the Disease Management benefit should be looked at.  The 
terms “as result of”, “as an advantage of”, “by virtue of” the employee’s employment 
confers the causal relationship. “By virtue of” would have the same meaning as “in 
respect of” and case law gives a meaning to it with the case of CIR v Crown Mines242 in 
which CJ Innes had said the tax could not be imposed “ in respect of a particular subject 
matter, unless it has a direct relationship to that matter” . In ITC 1683243 it was held that 
this phrase means “causal relationship”.  In CIR v Cowley244 it is stated that the phrase 
“in respect of” “...connotes a direct relationship of cause and effect, or origin and 
product...”.  In terms of the interpretation of case law there has to be a direct relationship 
between the specific employees’ employment; the cause and the benefit received for 
Disease Management; the effect.  
 
The employer through a series of employment contracts with the employees, where it is 
stipulated that Disease Management is made available to all employees whether the 
employees make use of the benefit or not now imposes a causal relationship between the 
employees’ employment contracts and the benefit available for Disease Management of 
HIV positive employees.  
 
A similar situation had arisen in English cases245 where the taxing Act had made a profit 
that had accrued to a person “by reason of his office”246. The interpretation of this 
English case by the judge in De Villiers v CIR247 is: “But if any principle was to be 
extracted from these decisions it was simply that when dual considerations were in play it 
                                                                                                                                                 
241 (Paragraph 16 (1) (b)), Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and 
including Act 45 of 2003 
242 CIR v Crown Mines Ltd (1923 AD 121) 
243 ITC 1683 (62 SATC 406) 
244 CIR v Cowley (23 SATC 276) 
245 De Villiers v CIR (4 SATC 86)  
246 Blakiston v Cooper (1909, A.C. 104) 
247 De Villiers v CIR (4 SATC 86) 
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was necessary to look to the dominant one as affording the true reason for the 
payment.”248 
 
The dominant consideration here or true reason for the taxable benefit is the Disease 
Management that will secure employment and as such will be the true reason of the 
employee’s office.  
 
According to Isrealsohn v CIR249 that if in any doubt as to the phrase “in respect of”, the 
construction to be adopted is the one that is more favourable to the taxpayer. 
 
As a deeming allowance exists in terms of paragraph 16 (1)250 or a platform exists for a 
deeming allowance, a taxable benefit exists in respect of the direct or causal relationship 
between the individual employees’ employment and the benefit received by HIV positive 
employees for Disease Management as a result of an agreement by the employer. By 
virtue of the facts that “other persons enjoy a benefit or advantage that would have 
constituted a taxable benefit”.. had the employee received the benefit. If the employer 
provides this benefit or advantage to protect the company’s human capital and where the 
benefit is described in an HIV/AIDS policy or described as a benefit or advantage in an 
employment contract, whether directly or indirectly by the employer a taxable benefit 
will exist for each employee. This benefit can be directly from the employer or indirectly 
from an associated institution or fund. In terms of the last portion of paragraph 
16(1)(b)251 “anything is done by the employer under an agreement, a transaction or an 
arrangement so as directly or indirectly to confer any benefit or advantage upon any 
person other than the employee (bold inserted).” 252 
 
As the Commissioner for Inland Revenue expects the employer to calculate the correct 
employee’s tax in terms of taxable benefit, the employer then calculates a taxable benefit 
                                                 
248 De Villiers v CIR (4 SATC 86)  
249 Israelsohn v CIR 1952(3) S.A. at 540 (18 SATC 247) 
250 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
251 Seventh Schedule, Income Tax Act no. 58 of 1962 as amended up to and including Act 45 of 2003 
252 Silke on South African Income Tax, 2004, (electronic copy) 
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in all employees’ hands in stead of the employee who benefits from the HIV/AIDS 
Disease Management. 
 
The Disease Management funding of HIV positive employees can be paid directly to the 
Disease Management company and the amount apportioned to all employees or the 
employer can contribute to a fund on behalf of the employees from where the Disease 
Management can be funded. Each employee contributes to say an HIV/AIDS Disease 
Management Fund to be managed by designated trustees. This is based on paragraph 
12(A) (1)253 where a contribution or benefit “..to any fund contemplated in paragraph (h) 
of the definition of ’ benefit fund’..”  
 
The amount taxable in the hands of each employee can be quantified by the Fund 
Administrators in very much the same way as suggested in paragraph 12(A) (2) for 
unallocated contributions. In the case of employees belonging to a medical aid the 
calculation of the unallocated benefit can be calculated according to paragraph 12(A) (2) 
and in the case of non-medical aid employees a directive can be sought from SARS in 
terms of how the unallocated benefit should be taxed. It can be suggested to SARS that 
paragraph 12(A) (2) can be used a basis for such a calculation.   
 
Paragraph 12(A) (2)254 allows for the apportionment of an “unallocated contribution” 
(defined as “B” in the formula quoted below) to a medical fund to all employees if the 
cost cannot be allocated to a specific employee. This paragraph calculates the taxable 
benefit so accorded by using the formula:  
 
A =  B  +  C   -   E 
  3 x D 
A = taxable benefit 
B = the total unallocated contribution to the fund for the benefit of the employees 
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C = contributions by all employees to the fund 
D = number of employees contemplated in B 
E = the contribution of the specific employee 
The individual contributions to the HIV/AIDS Disease Management Fund component 
therefore that is available to all employees, interpreted by SARS as a taxable benefit in 
terms of the Seventh Schedule should accordingly be taxed in every employee’s hand.   
  
This benefit to be taxed can be calculated quite comfortably, as a “cost-to-company” 
component already exists if the employer embarks on a VCT programme. The cost-to-
company component in the books of the company is recorded as a capitation cost because 
of the fact that the VCT process is voluntary and different numbers of employees attend 
different stages of the programme (see below). The employer can elect to have the 
designated expense specified as VCT on the company’s income statement or have it 
incorporated as cost-to-company. No taxable benefit exists for the employees if the 
process is “on-site” and therefore no direct taxable benefit is attributable to a specific 
employee and the confidentiality of the employees is protected.  
 
Had no taxable benefit been taxed in the hands of the employee the company would have 
included the Disease Management component as part of the VCT cost in the “cost-to-
company” component of remuneration as a section 11(a)255 deduction.  
 
When the company contracts with an outside provider for the VCT or Disease 
Management component the trend is to quote the company a price for the different 
programmes based on the possible HIV/AIDS prevalence of the company and the 
statistical chance of AIDS prevalence. A typical quote would allow for say: 
 100% pre-test counselling 
 80% testing 
 75% post-test counselling 
 10% confirmatory laboratory testing 
 2% for Disease Management. 
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(These percentages will differ depending on the province, race and gender 
demographics.) 
 
The cost-to company component is determined and the VCT and Disease Management 
programmes are embarked on. Below is a hypothetical case using 100 employees, an HIV 
prevalence of 10% and AIDS sick of 2%. The value calculated is very much in line with 
statistics given in (this article section 2 above)256  
 
 
 
EXAMPLE: CALCULATION OF TAXABLE BENEFIT AS ENVISAGED BY PARAGRAPHS 12(A)(2) 
       
Voluntary Counselling and Testing     
       
Description number % cost/  Total  
   employee/   
   Day    
Pre-test counselling 100 100 35 R 3500  
Testing 80 80 30 R 2400  
Post-test counselling 75 75 200 R 15000  
Confirmatory laboratory  10 10 75 R 750  
    R 21650  
Cost-to-company per 
annum 100   R 216.5  
(excluding Disease 
Management)       
Disease Management 2 2 33000 R 66000  
Cost-to-company per 
annum    R 660  
(excluding VCT)      
       
Total cost-to-company per 
annum   R 876.5  
Formula according to paragraph 12(2)(b)    
A= B + C - E     
 3 x D      
  A B C D E 
   unallocated Contributions number of contribution
   Benefit by all  Employees of specific 
    Employees  employee 
Taxable benefit per 
employee per year 
including VCT R 292.17 87650 0 100 0
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Interpreting the example cited above, an amount of R292.17 will be taxed in the hands of 
the employees assuming no medical aid contributions are made by the employees. The 
calculation will be more favourable for the employees if they do belong to a medical aid. 
The taxable benefit can be attributed on a monthly basis, allowing for a cost-to-company 
per month per employee of say R20 each per month for VCT and Disease Management. 
The taxable benefit will be restricted to the Disease Management component alone and 
hence will generate R66 per year per employee, in the cited example, resulting in a 
capitation cost of just over R5 per employee per month and the taxable benefit will be 
negligible. Granted if more than 2% of the employees were to contract AIDS and go for 
Disease Management the benefit will increase. 
 
Employees already belonging to a medical fund will now belong to a second fund that 
has to be set-up as contemplated by paragraph 2(i) as a medical fund or as a friendly 
society. Although outside the scope of this article opinions will have to be sought to 
determine whether this fund complies with the requirements of a friendly society and 
maybe even a medical fund. These employees will be taxed according to paragraph 12(B) 
if the contribution to the HIV/AIDS fund is seen as an unallocated benefit of the same 
medical fund. It is the author’s opinion that the contribution can be seen as a second 
medical aid contribution and taxed as such akin to an employee contributing to a medical 
aid and a hospital plan. 
 
Employees not belonging to another medical aid will be taxed as if though this 
HIV/AIDS fund is indeed a medical fund in terms of paragraph 2(i) if approved by 
SARS.  
 
All employees will have the taxable benefit reflected on their IRP5’s and hence no-one 
will be stigmatised and their anonymity will be secured.  
 
It is the author’s opinion that if all the employees feel that they are taxed on a benefit that 
only some utilise, it would motivate more employees to come forward to have their 
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HIV/AIDS status known. The taxable benefit will increase but it will secure a healthy 
work force with their HIV/AIDS status intact and monitored by an external HIV/AIDS 
Disease Management company.  
 
Should the Commissioner of Inland Revenue still seek to tax specific employees at the 
time of a payroll audit by SARS, the employer will then be in a position to object to 
SARS’ assessment of the taxable benefits given the fact that they had already attributed a 
taxable benefit based on the interpretation of paragraph 12(A) (2)257.  
 
If SARS were to argue that this benefit only exists for employees belonging to a medical 
aid, it can be argued that paragraph 16(1)(b)258 taxes a benefit available to “any person” 
as taxable in the hands of everyone that has an entitlement to the benefit. The 
interpretation will be the same as the cited example above other than that the medical aid 
contributions will have to be omitted from the example.  
  
For employees belonging to a medical aid paragraph 12(A)(2)259 will apply and for 
employees without a medical aid paragraph 16(1)(b)260 will apply as well as the deeming 
of paragraph 12(A)(2)261. 
 
The interpretation of paragraph 16 of the Seventh Schedule therefore affords the 
employer the opportunity to tax the benefit of Disease Management available to all 
employees although not enjoyed by all employees in the hands of each employee. The 
rationale that drives this interpretation is that the employees’ anonymity in terms of the 
Employment Equity Act has to be protected. Furthermore it subsidises the treatment for 
the small percentage of the work force that needs Disease Management without being 
stigmatised. 
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The solution proposed does not change the Income Tax Act nor does it remove tax 
completely from the equation, it does however propose an equitable solution for all. 
  
 
11.  CONCLUSION 
 
There is to date no medical cure for HIV/AIDS and no vaccine exists.  
 
There is no cure for sexual abstinence to safeguard HIV positive individuals from 
infecting HIV negative individuals. 
 
There is no immediate solution for poverty and poverty drives HIV infection.  
 
Government and Business however can make a difference by making individuals aware 
of HIV/AIDS and making it affordable to treat the disease. 
 
There seems to be a burden shift away from Government to employers to foot the bill for 
HIV/AIDS Disease Management.  
 
Government has a dissident view on HIV/AIDS and through their representatives at the 
SARS enforces the notion that HIV/AIDS should be seen as any other life threatening 
disease. The fact that the disease has the dimensions of a pandemic does not seem to 
change their view and employees receiving a Disease Management benefit from their 
employers are taxed on the benefit in terms of the Seventh Schedule of the Income Tax 
Act262. Through the imposition of this Act the employees loose their confidentiality as 
their status has to be known to their employer in order to gain a taxable benefit. 
 
The Employment Equity Act263 seeks to protect employees’ rights in terms of 
confidentiality but alas it prescribes that ‘any other law’ can extract information from an 
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employer. This includes the Income Tax Act264 and as such this Act is superior to the 
Employment Equity Act265. The employees’ confidentiality in terms of the Income tax 
Act266 is therefore not protected. 
 
Business leaders have different opinions regarding the taxing of HIV/AIDS Disease 
Management; these vary from a “hands-off” approach, to ignoring the provisions of the 
Income Tax Act267 to initiatives to change the Income Tax Act in order to protect the 
confidentiality of employees.  
 
BUSA has proposed three options to Government to change the Income Tax Act in order 
to protect the anonymity of employees and make the treatment more affordable. 
 
In this article comments were made on the various options proposed by Business Leaders 
and some initiatives with merit have been scrutinised and amended forms of some of the 
proposals were proposed.  
 
Further initiatives were proposed of which one is to make use donations to a Public it 
Organisation where employees can receive donations from the PBO in line with the 
general public at large. This solutions give the necessary anonymity for the individuals 
and give the employer as well as the employee the necessary tax free deduction without 
having to change the Income Tax Act, but will not get the desired support from probable 
donor companies as a perception could exist that the donations will be received in a 
bottomless pit where their employees will never benefit from.  
 
Another initiative offered by this article is the interpretation that if an employee has 
access to a benefit as a result of a general fund set up as an HIV/AIDS Disease 
Management Fund that all employees contribute to and hence receives a taxable benefit 
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for the capitation cost attributed to all the employees based on the Disease Management 
cost calculated for the HIV/AIDS infected employees and their spouses.  
This interpretation of paragraph 16(1) of the Seventh Schedule of the Income Tax Act268, 
 Complies with the Income Tax Act269 
 Complies with the Employment Equity Act270 
 Affords the employer a tax deduction 
 Taxes a minimal taxable benefit in the hands of the employee 
 Protects the anonymity of the recipient 
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